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Abstract 
Several studies have been conducted to detect the direct effect of inhibiting   the 
aromatase activity, the rate limiting enzyme that converts androgens to estrogens 
needed for ovarian differentiation in fish to overcome the immediate need for a more 
environmentally friendly substitute of methyl testosterone. Cyclooxygenase (COX2)-
inhibitors are potent and irreversible inhibitors of the COX2 pathway and since 
studies on human breast cancer cells shows that they decrease aromatase  messenger 
ribonucleic acid (mRNA) expression at the transcriptional level we tested the effects 
of supplementation of COX2-inhibitors (Etodolac and Etoricoxib)  in  the diets of fry 
tilapia on growth rate, and mortality.On the other hand, human and veterinary 
pharmaceuticals have been shown to occur in considerably high amounts in sewage 
treatment plant (STP) effluents and surface waters, with the non-steroidal anti 
inflammatory drugs representing one of the most commonly detected compounds. 
Information concerning possible ecotoxicological risks of these substances is rather 
scarce. So far there are no data available on their possible effects in fish after 
prolonged exposure. Thus, highlight on Etoricoxib pharmacokinetics was carried out 
by determination of Etoricoxib in fish feces using HPLC. The study was carried out at 
the Aquaculture research laboratory, in AlQuds University, Jerusalem.  At an age of 8 
days post – hatched 30 genetically mixed population of Oreochromis. niloticus larvae 
were stocked in duplicate, into aquariums each with a capacity of ≈ 45L in a closed 
system. Treatments included 5 different experimental diets and one standard diet 
serving as control with two repeats for each group from 0.5 % groups of diets. The 
test diets were prepared by mixing 600 mg of etodolac with 20g,60 g,30 g commercial 
feed, to achieve (0.5% etodolac,1%etodolac, 2% etodolac)concentrations respectively, 
the same process was done to the etoricoxib by mixing 90 mg of etoricoxib with 18 g, 
9 g, commercial feed, to achieve (0.5% etoricoxib,1% etoricoxib)  concentrations 
respectively. Another experiment was conducted using 10 adult mixed populations at 
age of 2 months stocked in triplicate in a closed system and, treated as above. Feeding 
started on the same day of stocking and fish were fed once daily. Feed was adjusted 
according to fish weight, by 10 % of their weight during the first four weeks and 5% 
of their body weight after changes of all diets to control diet. Fish were weighted 
every week and counted in each aquarium to determine survival rate during 12 weeks 
period. Individual fish in each aquarium was weighted to the nearest 0.1 g using a 
 
 
digital scale. The growth rate (GR) was determined using linear regression: yt = a + 
bxt, where yt is the average total weight (g) of the fishes at time t and a is the average 
weight (g) of fishes at the start of the experiment. Results showed that the different 
growth rate parameters (final body weight, weight gain and  growth rate (GR) of O 
niloticus fed with selective COX2 inhibitor Etodolac and Etoricoxib respectively were 
significantly affected with the highest growth rate obtained with the 0.5% etodolac 
followed by etoricoxib 0.5% followed by untreated sample. However, no increase or 
decrease of growth in mixed adult population was observed. Growth rate increased 
with increasing concentrations with the highest growth rate in the aquarium treated 
with (2% Etodolac) followed by (1% Etodolac), but (1% Etoricoxib) showed a 
decreased growth rate compared to standard which could indicates a toxic potential 
toward fish at this concentration. In addition, no peak for Etoricoxib was detected on 
HPLC in feces samples collected after half an hour, 1 hour, 2 hours, 3 hours and 4 
hours,24 hours following treatment with 1% etoricoxib diet in 4 months age tilapia. 
This reflected, that Etoricoxib, was well absorbed by tilapia, extensively metabolized 
with no unchanged fraction excreted, or may undergo enter hepatic circulation, 
increasing further its toxic potential. No mortality was observed in adult mixed 
population. In fish fry there were no differences in mortality rates between (0.5% 
Etodolac), and (0.5% Etoricoxib) treatments, but survival rate (96.6% and 90%) were 
improved compared to control (86.6%, 83.3%) during the experimental feeding. 
Higher mortalities were shown as concentrations increase with (1%Etoricoxib), (1% 
Etodolac) and (2% Etodolac). These results indicated that the inclusion of selective 
COX-2 inhibitor in fish diet efficiency was maximally exerted during critical period 
of sexual differentiation, which occurs in tilapia fry between 2 and 6 weeks after 
spawning. After finishing of this period there was no effect on the growth rate. Thus, 
COX inhibitors could modulate aromatase activity needed for proper sexual 
development and reproduction during the crucial period. Furthermore, this is the first 
time to our knowledge we test the effects of these agents on fry teleosts during the 
crucial period of sexual development which points to possible alterations in 
reproduction following chronic exposure to these drugs at an early stage in 
contaminated surface water. Subsequent field investigations in normal aquaculture 
bonds are needed to confirm these results in larger population, using different classes 
of COX-inhibitors at different concentrations. 
 
 
Chapter one 
Introduction 
1.1 Growth in NileTilapia:  
The growth rate of tilapia is determined by several factors and it is important to take all 
these factors into consideration. The growth rate will for instance be affected by water 
quality, temperature, oxygen levels and the general health of your fish. The type of food 
you provide them with and in which quantities will naturally also be of imperative 
importance. Last but not least, you have to pick an optimal stocking density. In addition to 
this, it is important to choose a species, hybrid or strain that is fitting for particular fish 
farm. Many producers advertise about strains with a super-fast growth rate, but this growth 
rate will not be attained unless the environment is ideal for that particular strain. You must 
for instance take the climate in your part of the world into account and the salinity level in 
the water you plan on using is also important.   
1.2 Growth rate in mixed-sex culture 
In a mixed-sex tilapia culture, the fish is normally harvested before the fish reaches sexual 
maturity or soon afterwards. This restricted culture period makes it even more important 
than normally to make the fish grow fast, since they have to reach their proper size within 
a limited time frame. It is therefore common to avoid dense stocking of mixed-sex tilapia 
cultures. It is also important to avoid using stunted fish since such fish will reach sexual 
maturity while they are still too small for the food market. Blue tilapia (Oreochromis 
aureus), Nile tilapia (Oreochromis niloticus) and their hybrids are common in mixed-sex 
cultures since they will attain a marketable size before commencing spawning. Species 
such as Mozambique Tilapia (Oreochromis mossambicus) and Wami tilapia (Oreochromis 
urolepis hornorum) are normally avoided since they will be too small when they reach 
sexual maturity. By choosing the right species or strains and providing the fish with a 
suitable environment and proper nutrition, it is possible to achieve a growth rate fast 
enough to allow fry produced in the spring to reach a marketable size by autumn in 
temperate regions. For a 4-5 month long culture period it is common to stock 2,000-6,000 
one month-old fry per acre in grow out ponds. With a stocking density of 4,000 fry per 
 
 
acre, the average weight at harvest can then be expected to be around 0.5 pounds (220 
grams), if supplemental feedings with protein rich food has been carried out.  
1.3 Growth rate for all-male fingerlings:   
In mono-sex cultures, it is common to opt for male fish only since the male tilapia grows 
faster and reaches a larger size than the female. All male batches can be obtained through 
hybridization, hormonal treatment or manual sexing and separation. It should be noted that 
none of these methods can guarantee 100% males in any batch. If you want really large 
tilapia, the amount of females in the growing unit should not exceed 4 percent. Many 
farmers therefore use more than one method to ensure a low degree of females in the 
growing unit. Predator fish of a suitable size can also be added to the growing unit to 
devour any offspring. All-male tilapia cultures are often densely stocked. This will 
decrease the individual growth rate of each fish, but it will normally result in a higher 
yield per unit area. Densely stocked cultures are more susceptible to ill-health and careful 
water management is recommended, since poor health can have a devastating effect on 
growth rate and lead to massive losses. The normal stocking rate for all-male tilapia 
cultures varies from 4,000 to over 20,000 fishes per acre. If you have no supplemental 
aeration, it is safest to stay in the lower range. In a suitable environment with an adequate 
supply of nutrition, it is possible for 50 gram fingerlings to become 500 gram fishes within 
6 months even without supplemental aeration if the stocking rate is 4,000/acre. This means 
an average growth rate of 2.5 grams per day and it is possible for such a culture to yield 
2.2 tons/acre.  A stocking rate of 8,000/acre can yield up to 4.4 tons/ acre, but will require 
night time emergency aeration. You can expect the average weight gain to be 1.5-2.0 
grams/day. The culture period will need to be at least 200 days, often more, if you want to 
produce fish that weighs almost 500 grams. Stocking rates above 12,000/acre will require 
extensive aeration, but can on the other hand yield up to 6-10 tons / acre. Keeping the 
water quality up will be difficult and you might have to resort to sub-optimal feeding rates 
and this will naturally affect the growth rate.  
Tilapia growth can generally be broken into three distinct phases: 
• Exponential or Accelerating Phase  
• Linear Phase  
• Decelerating or Plateau Phase  
 
 
Young fry are ravenous eaters and they can consume feed that is equivalent to up to 25% 
of their body weight daily. As a result, the fish grow very fast when measured in percent 
of body weight per day. This phase is referred to as the Exponential or Accelerating Phase. 
However, since the fish are initially very small, the total weight gain is initially low. This 
rate of weight gain (in grams per day) increases until the fish weigh approximately 100 
grams, at which point they enter the Linear Phase of growth. During the Linear Phase, 
Tilapia eats approximately the same amount each day and the growth remains fairly linear. 
Their feeding rate does not change drastically during this period because, although the fish 
are growing, they eat less feed as a percent of their body weight as they grow. The 
duration of the linear growth phase differs dramatically with the species and strain of 
tilapia. Some inferior strains may show growth deceleration at sizes of less than one 
pound. When fish growth begins to decelerate, they enter what is referred to at the Plateau 
Phase. At this point, it begins to take more food and time to achieve a given amount of 
growth. This can be very frustrating for the aquaculturist who is trying to get fish to 
market. Cheaper fingerlings often become more expensive in the long run due to poor 
genetics. During an in-house growth trial of AmeriCulture Tilapia, the linear growth phase 
of genetic males was maintained up to a size of approximately 3 pounds before 
decelerating. This is an important consideration for aquaculturists who want to get their 
fish to market size before they begin to plateau. Of course, the fish must be reared 
optimally from the time they arrive at your facility in order to achieve these types of 
results for practical reasons.  (www.Americulture.com) 
1.4 Sex reversal: - 
Sexual behavior is one of the most profound events during the life cycle of animals that 
reproduce sexually. After completion of gonadal development that is mediated by various 
hormones, oviparous teleosts perform a suite of behaviors, often termed as spawning 
behavior. This is particularly important for teleosts that have their gametes fertilized 
externally as the behavior patterns ensures the close proximity of both sexes for gamete 
release, fusion and ultimately the production of offspring. As in other vertebrates, sexual 
behavior of fish is also under the control of hormones. Testicular androgen is a 
requirement for male sexual behavior to occur in most fish species that have been studied. 
Unlike tetrapods, however, ovarian estrogen does not appear to be essential for the 
occurrence of female sexual behavior for fish that have their gametes fertilized externally. 
 
 
Prostaglandins produced in the ovary after ovulation act as a trigger in some teleosts to 
induce female sexual behavior. Potentiating effects of gonadotropin-releasing hormone in 
the brain on sexual behavior are reported in some species. Under endocrine regulation, 
male and female fish exhibit gender-typical behavior during spawning, but in some fish 
species there is also some plasticity in their sexual behavior. Sex changing fish can 
perform both male-typical and female-typical sexual behaviors during their lifetime and 
this sexual plasticity can also be observed in non-sex changing fish when undergoing 
hormonal treatment. Although the neuroanatomical basis is not clear in fish, results of 
field and laboratory observations suggest that some teleosts possess a sexually bipotential 
brain which can regulate two types of behaviors unlike most other vertebrates which have 
a discrete sex differentiation of their brain and can only perform gender-typical sexual 
behavior. 
1.5 Sex inversion by different methods  
1.5.1 Androgen treatment : - There are several techniques used to obtain a predominantly 
male population of tilapia and the most used technique in Israel is Chemical Sex Reversal : 
First feeding fry are fed a diet laced with methyl-testosterone (MT) or Ethinyl-testosterone 
(ET) for 21-30 days, at a dose of 60mg/kg feed. When done properly this technique is very 
effective, often resulting in populations greater than 95% male. The most commonly used 
drugs (MT and ET) are both not approved by the FDA, and known as carcinogenic. In 
many areas in USA and Europe the use of MT or ET is forbidden. Recently, it was found   
that it is possible to induce sex reversal of O. niloticus by egg immersion, an alternative 
technique from the traditional sex reversal method of feeding the fry with hormone-treated 
feeds. The highest average proportion of males (91%) was obtained at 800 µg/l 
comparable with the 88- 89% male obtained at 400µg/l and 600 µg/l at immersion time of 
96-hr. These values of percent males were lower compared to the reported average 
masculinization rate employing the traditional sex reversal using hormone-treated feed. A 
hormone administered at 40 mg/kg to first feeding fry for approximately 25 days fed 4 
times a day, can give an excess of 90% male, although 100% populations are seldom 
achieved.   
1.5.2 Genetic control: - The best way to obtain all-male populations is through genetic 
control (Baroiller et al., 1999). Based on the first data on tilapia sex determination and 
differentiation, it has been possible to produce genetically “all-male populations” through 
 
 
the development of YY “supermales” (Baroiller et al., 1999). Nevertheless, this approach 
is unreliable and hampered by the very long procedure of producing and identifying 
putative YY male individuals. Moreover, sex determination has been shown to be more 
complex than a simple agent XX / XY monofactorial system.  
1.5.3 Non-steroidal: - genetically female tilapia fry that were treated with Fadrozole, a 
non steroidal aromatase inhibitor, in the diet during the period of sexual differentiation 
showed a dose- dependent increase in the percentage of males (Kwon et al., 2001). In the 
current work we will try to use non-steroidal agents for sex reversal.  
1.5.4 Environment and sex inversion: - Environmental factors (temperature, pH, density 
and social interactions) could influence the sex ratio in gonochoristic species. In fish, the 
main environmental factor influencing sex seems to be temperature. In tilapia, as thermo 
sensitive species, male to female ratio increases when temperatures were higher than 32ºC 
(Baroiller et al., 1999).Despite the fact that the fate of the gonad is determined genetically, 
temperature can override it and switch the mechanism when the gonad is undifferentiated. 
But once the decision is established it cannot be modified anymore, being committed 
towards the development of one sex .The critical period of gonad differentiation in tilapia 
has been established from 9 to 15 days post fertilization (Ijiri et al., 2008). Temperature or 
hormonal treatments have to be applied from this period onwards to be efficient. Despite 
the strong genetic basis for determining sex in tilapia it is now clear that other factors are 
also acting on sex. A strong effect of temperature on sex differentiation has been 
demonstrated in various tilapia species and in a hybrid (Baroiller et al., 1999). It was 
possible to masculinise XX tilapia progenies 100% females with elevated temperatures 
above 32 °C, giving functional male phenotypes. The use of female monosex populations 
as well as the progeny testing of temperature treated males, has definitely demonstrated 
the existence of skewed male sex ratios corresponding to a sex-inversion of   19genetic 
females (XX) to functional phenotypic males. These thermo-neomales provide in their 
offspring all-female or almost all-female progenies depending on the breeders. High 
temperatures could efficiently masculinise some progenies if started around 10 days post 
fertilization (dpf) and if applied for at least 10 days, with longer periods being just as 
effective.  Recently, demonstrated that even a precocious elevated temperature-treatment 
applied 12 h post fertilization (hpf) and kept for 52±2 h till hatching, can also induce 
significantly skewed sex ratios towards males (8–27%, n=4) on a true all-female progeny 
 
 
100% females in the control group. Even if the high mortality associated to the 
precociously high temperature treatment (35–36 °C) has to be considered, this data 
strongly suggest that there is a thermo sensitivity window very shortly after fertilization 
(between 12 and 52 hpf (=4 dpf)), long before the development of the presumptive gonads.  
1.6  Fish ovarian aromatase:   
 The aromatase enzyme is part of an enzymatic complex which includes the cytochrome 
P450 aromatase, the product of the cyp19a1 gene, and a NADPH-dependent cytochrome 
P450 reductase known as a ubiquitous flavoprotein. Aromatase is a microsomal enzyme 
localized in the smooth endoplasmatic reticulum of steroidogenic cells. Interestingly, it has 
been stressed that its high affinity for the substrates facilitates estrogen synthesis even 
when androgens are not synthesized in high concentrations. In fish, only a few kinetic 
studies have been performed, and mostly in tissues potentially expressing both aromatase 
genes (cyp19a1a and cyp19a1b). The enzyme has more or less similar affinities for 
androstenedione and testosterone, and the Michaelis–Menten affinity constant (Km) is 
usually in the nanomolar range (<10 to _400), whereas the catalytic maximum activity is 
in the order of fmol–pmol/mg protein/hour (Hinfray et al., 2006). The effects of estrogen 
treatment on fish sex differentiation have been investigated since the fifties, however, 
physiological and molecular studies on the role of estrogens in fish have initially been 
developed mainly in relation to vitellogenesis. Their biosynthesis potentiality was looked 
for in immature or developing ovaries using testosterone or androstenedione as a substrate, 
although androstenedione has been shown to be more efficiently metabolized in rainbow 
trout and goldfish (Zhao et al., 2001). These studies have mainly focused on the 
production of estradiol-17b (E2) and estrone, while estriol has rarely been identified in 
fish, but other estrogen metabolites would be worth considering. For instance, 
glucuronides and sulfates of estrogens are not only produced in adults but also in larvae 
during the sex differentiation period (Yeoh et al., 1996a,). The enzymes responsible for the 
hydrolysis of conjugated steroids might then also play a role in the local regulation of the 
concentrations of biologically active estrogen metabolites, but they are poorly known in 
fish. Besides, several unknown free or conjugated metabolites of estrogens have been 
found to be produced by whole fish embryos or their gonads during the sex differentiation 
period (Rowell et al., 2002) or in transitional gonads during sex change in a protandrous 
hermaphrodite species, but their possible biological activity is not known today. 
Interestingly, ovarian catecholestrogens, 2/4-hydroxyestradiol-17b and 2-
 
 
methoxyestradiol, have been found recently in stinging catfish, Heteropneustes fossilis, 
and these compounds have even been shown to modulate the ovarian aromatase activity. 
 
1. 7 Aromatase enzyme and estrogens during natural sex differentiation 
Estrogens have been considered as female-promoting steroids in gonochoristic fish species 
since the pioneering work of Yamamoto (1969). This assumption was first based on the 
fact that feminization was observed when estrogens were administered exogenously 
during early development in fish. This led to the hypothesis that estrogens were 
gynoinductors, triggering ovarian differentiation, and androgens were androinductors, 
driving (Yamamoto, 1969). These early studies were then confirmed by a large number of 
other experiments showing that estrogen treatments were highly effective in feminizing 
many fish species (Piferrer, 2001). Besides these feminizing effects of estrogens, 
treatments with aromatase inhibitors (AI) that blocked estrogen synthesis were found to 
induce masculinization when applied during the sex  differentiation period in Chinook 
salmon, Oncorhynchus tshawytscha (Piferrer et al., 1994), Nile tilapia (Guiguen et al., 
1999; Afonso et al., 2001; Kwon et al., 2002), rainbow trout (Guiguen et al., 1999), 
zebrafish (Fenske and Segner, 2004), Japanese flounder, golden rabbitfish, Siganus 
guttatus, Japanese fugu and common carp, Cyprinus carpio. These results have been 
crucial in the understanding of fish gonadal differentiation as they demonstrated quite 
unambiguously that estrogens were major endocrine factors in determining gonadal sex-
fate, as their synthesis was required to trigger ovarian differentiation and their depletion 
was sufficient to trigger testicular development. Until recently sex differentiation was also 
thought to be a rather irreversible fate in gonochoristic fish. Thus, sex inversion treatments 
in fish were always applied during a so-called sex differentiation period with only a few 
reports suggesting that this sensibility to sex inversion treatments could be extended to 
adult fish. In post differentiated Nile tilapia females, AI treatment was able to induce a 
partia l, but functional, masculinization of the gonad. This may actually be a more wide 
spread feature than previously thought, since it was also observed recently in common 
carp. This sheds new light on the implication of estrogens in gonadal differentiation, as 
these experiments clearly demonstrated that estrogens are probably not only needed for 
triggering ovarian differentiation, but are also needed to maintain this ovarian 
differentiation. The effects of specific estrogen receptor antagonists, such as tamoxifen 
have also been investigated. With tamoxifen treatments, either no deviation of the sex ratio 
(Guiguen et al., 1999), or masculinization of genetic females (Sun et al., 2007) have been 
 
 
observed, although in many cases no complete masculinization could be obtained. This, 
however, indicates that any impairment of the classical estrogen signaling pathway leads 
to some degree of masculinization. 
 
1. 8 Germ cell proliferation, gonadal estrogen production and ovarian differentiation 
Experimental germ cell depletion during the early steps of gonadal differentiation has 
recently been shown to produce masculinization of gonads in Japanese medaka genetic 
females (Shinomiya et al., 2001) and also in zebrafish. These masculinizing effects are 
supposed to be in relation to the intimate cross-talk between germ cells and somatic cells 
during the early sex differentiation steps of the gonad (Tanaka et al., 2008). From these 
observations it has been suggested that somatic cells in the gonad would autonomously 
activate a male phenotype, and that germ cells would allow the activation of the female 
phenotype by sending signal(s) to both repress male predisposition and maintain 
feminization (Tanaka et al., 2008). This assumption fits well with the above discussion 
suggesting that ovarian somatic cells need to maintain their fully differentiated phenotype 
in order to produce estrogens that in turn will support their differentiation. Any disruption 
of this germ cell/somatic cell cross-talk would then disrupt ovarian somatic cell 
differentiation, leading to an absence of estrogen synthesis and a subsequent 
masculinization. But more subtle regulations involving not only the complete loss of germ 
cells, but instead some differential germ cell proliferation rates, could then be also 
suspected as important triggers of gonadal sex differentiation, These germ cell 
proliferation rates could eventually be affected by endogenous estrogen levels as 
suggested by some authors. In this respect, the bioavailability of active E2 from the 
hydrolysis of its sulfate counterpart would also be worth considering. In agreement with 
the hypothesis that germ cell proliferation could affect gonadal differentiation, point to the 
fact that this germinal/somatic cell cross-talk could also be involved in the natural gonadal 
differentiation of zebrafish as germ cell apoptosis always precedes testicular 
differentiation in this species (Uchida et al., 2002). In this respect, it is interesting to note 
that proliferation of germ cells has been often found to be more active during ovarian 
differentiation, than during testicular differentiation and that masculinizing high 
temperatures in thermo sensitive fish species have an opposite effect by stimulating germ 
cell apoptosis. It is also quite intriguing to see that the Japanese medaka sex determining 
gene, dmrt1Y (dmy), has been found to be an inhibitor of germ cell proliferation and is 
only expressed during testicular differentiation (Kobayashi et al., 2004). In the same 
 
 
context, the Japanese medaka hotei mutation affecting the anti-Mullerian hormone 
receptor (amhr2) leads to an increase in germ cell number and some male to female sex 
reversions. However, and apparently in contradiction with these results, anti-Mullerian 
hormone (amh) has also been found to be required for proliferation of germ cells in the 
same species (Shiraishi et al., 2007). Another tgfb member, the gonadal soma-derived 
growth factor (gsdf), was also described in rainbow trout as a potential stimulator of 
primordial germ cell and spermatogonia proliferation. However, like amh, gsdf is also 
expressed in both sexes, albeit at much higher levels during testicular differentiation 
(Baron et al., 2007). Thus, any sex specific effect of these tgfb members on germ cell 
proliferation should either be a function of their local protein abundance or of their 
concerted action with additional partners. For instance, follistatin (fst) has been found to 
be expressed at much higher levels during ovarian differentiation in rainbow trout (Baron 
et al., 2005b) and is also known to maintain germ cell survival in the mouse ovary (Yao et 
al., 2004) 
.                                        
 
 
Figure (2 .1) Germ cell proliferation in mouse. (Yao et al., 2004) 
 
 
 
1.9 Prostaglandin  
The prostaglandins are biologically active derivatives of arachidonic acid and other 
polyunsaturated fatty acids that are released from membrane phospholipids by 
phospholipase A2. The initial transformation of arachidonic acid involves oxygenation and 
cyclization to an unstable endoperoxide intermediate, prostaglandin (PG1) G2 by 
cyclooxygenase (COX) enzymes. The same enzymes reduce PGG2 to PGH2 via a separate 
peroxidase site. Various isomerases and oxidoreductases convert PGH2 to prostaglandins 
and thromboxane A2. The cyclooxygenase exists in two forms, the constitutive COX-1 
and the induced form, COX-2. Whereas the traditional NSAIDs inhibit both COX-1 and 
COX-2, the more recently developed anti-inflammatory coxibs inhibit COX-2 
preferentially. ProstaglandinE2 exerts its actions via four types of receptors, (EP1, EP2, 
EP3, and EP4). PGE2 plays a role both in normal physiology and in pathology. The 
biological actions include areas such as inflammation, pain, tumorigenesis, vascular 
regulation, neuronal functions, female reproduction, gastric mucosal protection, and 
kidney function. The formation of PGE2 from PGH2, formed by COX-1 or COX-2 is 
catalyzed by isomerases, PGE synthases. There has been an explosive development of our 
understanding of these enzymes triggered by the discovery of mPGES-1, which belongs to 
a recently defined superfamily membrane-associated protein in eicosanoid and glutathione 
metabolism (MAPEG). This superfamily also contains leukotriene C4 synthase and 5-
lipoxygenase-activating protein as well as three glutathione transferases/peroxidases called 
microsomal glutathione transferase 1–3 (MGST1–3). Microsomal glutathione transferase 1 
is the best characterized for substrate specificity, kinetic mechanism, and three-
dimensional structure and, being the closest relative to mPGES-1 (38% identity), serves as 
a good model for generating hypotheses on structure function relationships. mPGES-1 has 
emerged as a potential target for the development of drugs for treatment of inflammation, 
pain, cancer, atherosclerosis, and stroke.  
 
1.9.1 Prostaglandin in Fish  
Cyclooxygenase has been sequenced in several fish species, including the rainbow trout 
(Oncorhynchus mykiss) (Zou et al., 1999), Brook trout (Salvelinus fontinalis) (Roberts et 
al., 2000), Atlantic croaker (Micropogonias undulates), and zebrafish (Danio rerio) 
(Grosser et al., 2002). These species, along with genomic sequence data from the 
stickleback (Gasterosteus aculeatus), green spotted puffer (Tetraodon nigroviridis), 
 
 
pufferfish (Takifugu rubripes), and Japanese medaka (Oryzias latipes) suggest that fishes 
posses both COX-1 and COX-2 forms (Jarving et al., 2004). Furthermore, COX-2 has 
recently been sequenced from European sea bass (Dicentrarchus labrax) (Buonocore et al., 
2005) and euryhaline killifish (Fundulus heteroclitus) (Choe et al., 2006), supporting this 
prediction. A cyclooxygenase has also been sequenced from the spiny dogfish shark 
(Squalus acanthias) (Yang et al., 2002). However, this form was not designated as COX-1 
or COX-2 because of its near equal identity to both forms (it is only slightly more similar 
to COX-1). This form may represent an evolutionarily distinct form of cyclooxygenase 
found in the elasmobranchs. Ishikawa and colleagues have recently further characterized 
COX evolution in the teleosts by demonstrating that both the zebrafish (Ishikawa et al., 
2007) and rainbow trout (Ishikawa and Herschman, 2007) have two functional COX-2 
genes (named COX-2a and COX-2b). In addition, by analyzing sequence databases, they 
concluded that not all teleosts have two COX-2 forms, but that the stickleback, green 
spotted puffer, pufferfish, and Japanese medaka have two COX-1 forms instead (named 
COX-1a and COX-1b) (Ishikawa et al.,  2007). They concluded that a genome duplication 
before the teleosts, and a subsequent loss of either one COX-1 or COX-2 form 
characterizes the species mentioned (Ishikawa and Herschman 2007). This is supported by 
the apparent genome duplication events in teleosts. 
 
1.10 Cyclooxygenase function in fish  
Cyclooxygenase has likely been studied in the fishes more than other non-mammals due to 
their status as model organisms. As noted above, COX forms have been found in several 
species and along with genomic sequence data there is a general consensus that fishes 
possess both COX-1 and COX-2 forms that are homologous to those found in mammals. 
However, there is recent evidence that teleosts also possess an additional form of COX-1 
or COX-2 (Ishikawa et al., 2007; Ishikawa and Herschman, 2007) and some functional 
data also exist for these forms.  
 
1.10.1 Osmoregulation  
In fishes, the gills are the dominant site of acid/base regulation, nitrogenous waste 
secretion, gas exchange, and ion transport (Evans et al., 2005). Several studies have 
investigated the osmoregulatory role of COX in the gills of the euryhaline killifish, 
Fundulus heteroclitus. This teleost can withstand instant salinity transfer between full 
strength seawater and fresh water without any apparent physiological stress (Wood and 
 
 
Laurent, 2003).  One study showed that short circuit current across the opercular 
epithelium (a tissue with known ion transport capabilities) was reduced by using a non-
specific COX inhibitor (Evans et al., 2005). This suggests that COX-2 plays a role in ion 
transport in fish that may be similar to its function in the kidneys of mammals. Further 
studies supported this initial hypothesis by showing that COX-2 is expressed most 
abundantly in the gill, opercular epithelium, and kidney of the killifish (Choe et al., 2006), 
tissues that are known to be involved in ion transport in fish. This is supported in the 
zebrafish, which shows the highest levels of COX-2 in the gills (Grosser et al., 2002). 
Furthermore, COX-2 was localized in mitochondrion-rich cells in the gills of killifish, the 
main sites of ion uptake and secretion in the gills (Choe et al., 2006). Finally, COX-2 
expression was shown to significantly increase following either hypotonic or hypertonic 
salinity transfers, suggesting COX-2 may play a role in maintaining cell homeostasis or 
promoting cell survival during periods of osmotic shock (Choe et al., 2006). Taken 
together, these results strongly suggest that COX-2 in the gills of teleosts acts in the same 
way as COX-2 in the kidneys of mammals, including regulating ion transport and 
promoting cell survival. Cyclooxygenase has also been shown to play an osmoregulatory 
role in the rectal gland of the dogfish shark, Squalus acanthias. Sharks rely on the rectal 
gland rather than the gills for regulation of salt secretion and a COX form (sCOX) has 
been cloned from the rectal gland (Yang et al., 2002). This form was expressed most 
abundantly in the rectal gland of the shark, where PGE2 production was also high (Yang 
et al., 2002). Finally, using a COX-2 specific inhibitor, vasoactive intestinal peptide 
mediated chloride secretion decreased in the rectal gland, but then recovered following 
removal of the inhibitor (Yang et al., 2002). Even though sCOX is slightly more similar to 
COX-1 of mammals than COX-2, this result can be explained by the presence of valine at 
position 523 instead of isoleucine (and thus conferring COX-2 inhibitory properties). This 
result suggests that sCOX plays a role in ion transport in the rectal glands of sharks that 
may be similar to the gills of teleosts or the kidneys of mammals. The osmoregulatory role 
of COX in fish needs to be examined in greater detail using other species and diverse 
techniques. This may be highly feasible because COX sequences exist for a wide range of 
teleosts.  
 
1.10.2 Reproduction  
As in mammals, COX has been shown to play a role in reproduction in fish. By using the 
non-specific COX inhibitor indomethacin, it was shown in the Atlantic croaker 
 
 
(Micropogonias undulatus) that COX pathways may play a role in the maturation of 
ovarian follicles and ovulation through prostaglandin formation, although other proteins 
may play a more dominant role (Patino et al., 2003). Results from the European sea bass 
also indicate a similar role for prostaglandins in ovulation, with indomethacin inhibiting 
follicle maturation (Sorbera et al., 2001). However, it has been shown in the brook trout 
that indomethacin does not block ovulation, although it does in other fish species (Goetz et 
al., 1991). This apparent loss of function in the brook trout may be explained by changes 
in the levels of COX-1 and COX-2 during ovulation. It was shown that COX-1 levels 
remained constant and high during ovulation but that COX-2 levels did not increase prior 
to ovulation as they do in mammals (Roberts et al., 2000). This is supported by data from 
the zebrafish which show high levels of COX-1 but not COX-2 in the ovaries (Grosser et 
al., 2002). This suggests that COX-2 function in the reproduction of the brook trout is 
different than in other vertebrates. In the Japanese medaka, it was shown that low chronic 
levels (perhaps comparable to those found in waste water) (Metcalfe et al., 2003) of the 
non-specific COX inhibitor ibuprofen causes altered reproduction by decreasing the 
number of spawning events but increasing the number of eggs per spawning event (Flippin 
et al., 2007). This conforms to delayed pregnancies associated with NSAID use in 
mammals. These results indicate that COX likely plays a role in fish reproduction, 
although it may vary among species.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Two 
   Effect of pharmaceutical on the aquatic environment  
 
2.1 NSAIDs : 
Non steroidal Antiinflammatory Drugs (NSAIDs),chemically heterogeneous large groups 
of drugs which suppress inflammation in a manner similar to steroids, but less side effects 
of sedation, respiratory depression, or addiction than steroids. They are widely used for the 
treatment of inflammatory disorders and painful conditions such as rheumatoid arthritis, 
gout, bursitis, painful menstruation, and headache. They are effective in the relief of pain 
and fever. NSAIDs inhibit the cyclooxygenase (COX) activity resulting in decreased 
synthesis of prostaglandin, leukotriene and thromboxane precursors such as the ubiquitous 
enzyme which catalyzes the initial step in the synthesis of prostanoids. Prostanoid is any 
of a group of C-20 fatty acids complex with an internal five or six carbon rings such as 
prostaglandins, prostanoic acid, prostacyclins, and thromboxane; derived from arachidonic 
acid (C-20 polyunsaturated fatty acid with four cis double bonds). The action or the 
synthesis of prostanoids are involved in the modulation of a variety of pathophysiologic 
processes including inflammation, hemostasis, thrombosis, cytoprotection,  ulceration, 
hemodynamics and other the progression of kidney diseases. Thus, NSAIDs as non-
selective inhibitors of the cyclooxygenases (both the cyclooxygenase-1 and 
cyclooxygenase-2 isoenzymes) may have beneficial as well as untoward effects on a 
variety of human diseases. Low stomach prostanoid levels caused by COX-1 inhibitors 
can result in ulceration and internal bleeding and perforation. The selective COX-2 
inhibitors such as oxicam, meloxicam, and coxibs (celecoxib, rofecoxib, valdecoxib, 
parecoxib and etoricoxib) do not interfere with COX-1. The most prominent NSAID is 
aspirin 
2.2 ETORICOXIB 
 
Etoricoxib or 5-chloro-6’-methyl-3-[4-(methylsulphonyl) phenyl]-2, 3’-bipyridine is the 
newest addition to the group of non-steroidal anti-inflammatory drugs (NSAIDs) known 
 
 
as selective cyclooxygenase-2 inhibitors. Its chemical structure is shown in the Fig(2:2).  
Being the latest molecule, very few HPLC methods are reported in the literature. 
 
Figure (2:1) Etoricoxib chemical structure 
Etoricoxib (brand name Arcoxia worldwide; also Algix and Tauxib in Italy) is a COX-2 
selective inhibitor (approx. 106.0 times more selective for COX-2 inhibition over COX-1) 
from Merck & Co. Doses are 60, 90 mg/day for chronic pain and 120 mg/day for acute 
pain. Currently it is approved in more than 60 countries worldwide but not in the US, 
where the Food and Drug Administration (FDA) requires additional safety and efficacy 
data for etoricoxib before it will issue approval. Current therapeutic indications are : 
treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, 
chronic low back pain, acute pain and gout. Note that approved indications differ by 
country. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 
2 of cyclo-oxygenase enzyme (COX-2). This reduces the generation of prostaglandins 
(PGs) from arachidonic acid. Among the different functions exerted by PGs, their role in 
the inflammation cascade should be highlighted. COX-2 selective inhibitor showed less 
marked activity on type 1 cyclooxygenase compared to traditional non-steroidal anti-
inflammatory drugs (NSAID).This reduced activity is the cause of reduced gastrointestinal 
toxicity, as demonstrated in several large clinical trials performed with different. Some 
clinical trials and meta-analysis showed that treatment with some coxibs (in particular 
Vioxx, rofecoxib) led to increased incidence of adverse cardiovascular events compared to 
placebo. Because of these results, some molecules were withdrawn from the market 
(Rofecoxib, September 2004 and Valdecoxib, April 2005). In addition, the FDA and 
EMEA (USA and European Community Health Authorities respectively) started a revision 
process of the entire class of both NSAID and COX-2 inhibitors. 
 
 
 Etoricoxib, that is used for patients with chronic arthropathies and musculoskeletal and 
dental pain, is absorbed moderately when given orally. A study on its pharmacokinetics 
showed that the plasma peak concentration of etoricoxib occurs after approximately 1 
hour. It has shown to be extensively bound to plasma albumin (about 90%), and has an 
apparent volume of distribution (VD) of 120 L in humans. The area under the plasma 
concentration-time curve (AUC) increases in proportion to increased dosage (5-120 mg). 
The elimination half-life is about 20 hours in healthy individuals, and such long half-life 
enables the choice to have once-daily dosage. Etoricoxib, like the other coxibs, is excreted 
in urine and feces and also metabolized in likewise manner. CYP3A4 is mostly 
responsible for biotransformation of etoricoxib to carboxylic acid metabolite, but a non 
CYP450 metabolism pathway to glucuronide metabolite is also at hand. A very small 
portion of etoricoxib (<1%) is eliminated unchanged in the urine. Patients with chronic 
renal insufficiency do not appear to have different plasma concentration curve (AUC) 
compared to healthy individuals. It has though been reported that patients with moderate 
hepatic impairment have increased plasma concentration curve (AUC) by approximately 
40%. It has been stated that further study is necessary to describe precisely the relevance 
of pharmacokinetic properties in terms of the clinical benefits and risks of etoricoxib 
compared to other clinical options. (Brautigam et al., 2003) . 
2.3 ETODOLAC 
 
Etodolac or 1, 8-diethyl-1,3,4,9-tetrahydropyano[3,4-b] indole-1-acetic acid, is a non-
steroidal anti-inflammatory drug which has been shown to be effective in the treatment of 
rheumatoid and osteoarthritis and a selective COX-2 inhibitors in a wide range of clinical 
relevant assays in direct comparisons with other NSAIDs. Its chemical structure is shown 
in figure (2:2). Etodolac is metabolized in humans by hydroxylation and acyl 
glucuronidation to yield the corresponding 1-O-glucuronides. The acylglucuronides of 
etodolac and one of its hydroxylated metabolites were determined by.  By HPLC using a 
RP18 column. In order to increase the lipophilicity of these metabolites the hydroxy 
groups were acetylated and the carbonilic functions were methylated. The S-etodolac-
glucuronide is mainly excreted during the first 6-hours. (Berendes&Blaschke., 1996) 
                        
 
 
 
Figure (2:2) chemical structure of Etodolac 
 
Etodolac, indole analog compound, is a NSAID (nonsteroidal anti-inflammatory drug) of 
non-selective inhibitor of COX-1 and COX-2. It is used as an analgesic and anti-
inflammatory for the treatment especially arthritis. Its chemical designation is (±)-1,8-
diethyl-1,3,4,9- tetrahydropyrano- [3,4-b]indole-1-acetic acid. It is a white crystalline 
compound insoluble in water, soluble in alcohols, chloroform, DMSO and polyethylene 
glycol; administered orally. (www.drugbank.com)  
 
2.4 Cyclooxygenase Inhibitors 
 
In 1971, Vane reported that aspirin and indomethacin inhibit the biosynthesis of 
prostanoids and shortly after it was established that these inhibitors block the oxygenation 
of arachidonic acid. COX-1 and 2 are the major targets of NSAIDs including aspirin, 
ibuprofen, and the new COX-2 inhibitors. Even though cyclooxygenases have both 
cyclooxygenase and peroxidase activities, NSAIDs only block the cyclooxygenase part. 
NSAIDs can be grouped into three classes based on their modes of COX inhibition: (a) 
Class I – simple, competitive, reversible inhibitors that compete with arachidonic acid for 
binding to the COX active site (e.g. ibuprofen)  (b) Class II - competitive time dependent, 
reversible inhibitors that bind to the COX active site in a first phase, to form reversible 
enzyme inhibitor complexes, that if retained for a sufficient time, cause a non covalent 
conformational change in the protein, associated with tighter binding (e.g. indomethacin) 
or (c) Class III – competitive, time dependent, irreversible inhibitors that form an enzyme 
inhibitor 
Complex after a covalent conformational change in the protein (e.g. aspirin). The 
discovery of COX-2 in 1991, the key enzyme involved in inflammation, set a new goal for 
 
 
researchers. The new goal was to develop COX-2 selective inhibitors to avoid the 
numerous side effects associated with COX-1 inhibition. The new concept brought another 
classification for NSAIDs as selective or non-selective depending on their specificity at 
inhibiting one of the isoforms or both. These efforts have culminated with the introduction 
of successful drugs like celecoxib as a potent anti-inflammatory agent for the treatment of 
arthritis. 
 
2.5 Association between Non-steroidal Anti-inflammatory Drugs (NSAIDs) and 
breast Cancer 
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to decrease inflammation by 
inhibiting cyclooxygenases. Even though the Nurses’ Health Study found no difference in 
aspirin intake among women who developed breast cancer and those who did not, a 
growing body of experimental and epidemiological evidence suggests that the use of 
NSAIDs may decrease the risk of breast cancer. In a case-control study, a 40% reduction 
in breast cancer incidence was observed in women who reported daily intake of aspirin, 
ibuprofen, or other NSAIDs for at least 5 years. Independent studies found that both 
indomethacin and ibuprofen reduced the incidence of dimethylbenz[a]anthracene-induced 
mammary tumors in rats. Celecoxib and ibuprofen produced striking reductions in the 
incidence of mammary cancer, tumor burden, and tumor volume compared to those seen 
in the control group in animal models. Aspirin and flurbiprofen were shown to reduce 
mammary tumorigenesis. Genetic and pharmacological evidence has shown that specific 
COX-2 inhibition is more effective than traditional NSAIDs in suppressing polyposis in 
the mouse. SC-560, celecoxib, and indomethacin treatment resulted in statistically 
significant inhibition of tumor size in comparison with vehicle-treated control animals in a 
murine model of breast cancer. Regular intake of NSAIDs for 2-5 years was associated 
with a 24% reduction in invasive breast cancer. All these findings suggest that 
cyclooxygenases are involved in the promotion of this type of cancer. The relationship 
between cyclooxygenases and aromatase was examined in a preliminary study of CYP19 
gene expression with COX-1 and COX-2 gene expression in breast cancer patient 
specimens. This study showed that the levels of CYP19 gene expression remained 
relatively constant in breast cancer tissue with an increased expression in tissue showing 
signs of invasion. While COX-1 was present in both normal and cancerous tissue, COX-2 
 
 
was only present in cancerous tissue with a significant linear association between tumor 
cell density and COX-2 gene expression. 
Regression analysis using a bivariate model showed a strong linear association between 
the sum of COX-1 and COX-2 expression and CYP19 expression.  Another study using 
immunohistochemistry staining for aromatase and COX-2 in tumor samples revealed a 
marked correlation between COX-2 and aromatase expression in tumor samples. These 
data confirm the previous reports showing a positive correlation for CYP19 and 
cyclooxygenases. These observations suggest that both autocrine and paracrine 
mechanisms may be involved in growth and progression of human breast cancer via 
stimulation of estrogen production regulated by a high biosynthesis of prostaglandins. 
Intratumoral aromatase may be important as a source of estrogens for tumor growth and 
intratumoral COX-2 may be important in the production of prostaglandins (such as PGE2) 
to direct aromatase gene expression through promoter II. PGE2, mainly produced by the 
epithelial cancer cells, up regulates aromatase expression and activity in the stromal 
neighboring cells through binding to the EP1 and EP2 receptors. A higher expression of 
aromatase could result in higher levels of estrogens. The resulting increased estrogen 
biosynthesis in local sites in turn may result in increased growth and development of the 
tumor by both paracrine and autocrine actions. (Brueggemeier et al., 1999) pointed to 
linear dependence between aromatase gene (CYP 19) expression and expression of COX-2 
in mammary carcinoma. The above mentioned facts predetermine the use of NSAIDs in 
mammary carcinogenesis prevention.Cyclooxygenase inhibitors suppress aromatase 
expression and activity in breast cancer cells (Diaz-Cruz et al ., 2005).  
 
2.6 Impact of NSAIDs in fish 
 
Information concerning possible sublethal effects of NSAIDs on aquatic organisms is 
scarce. In most cases, studies have been restricted to short-term acute lethality tests in 
algae, invertebrates and fish (Webb, 2001). However, chronic exposure to diclofenac in 
rainbow trout revealed histopathological alterations and cytological effects in liver, 
kidney, gills and intestine that were correlated with a dose-related tissue accumulation of 
the drug (Schwaiger et al., 2004). These studies are consistent with the well known 
gastrointestinal toxicity by NSAIDs in mammals.  histological analysis in fish revealed an 
increase in granulocyte numbers in primary gill filaments, as well as granulocyte 
accumulation and enhanced major histocompatibility complex (MHC) II expression in 
 
 
kidney, suggesting an inflammatory response in these organs (Hoeger et al., 2005). In 
addition, diclofenac, at sublethal but environmentally relevant concentrations, inhibited 
the EROD activity in primary cultures of trout hepatocytes, suggesting potential impact on 
biotransformation of xenobiotics in fish. NSAIDs are widely used for their analgesic and 
anti-inflammatory properties. The therapeutic effects are based on the fact that their 
amphiphilic acid structure binds to the lipid-water interphase of cell membrane proteins 
such as the prostaglandin-G/H synthase and inhibit their function. This enzyme exhibits 
two catalytic activities, hydroperoxidase and cycloooxygenase, which together catalyze 
the transformation of arachidonic acid to prostaglandins (PGs) and thromboxanes. Most 
NSAIDs are known inhibitors of cyclooxygenase activity. For instance, ibuprofen, 
indomethacin, diclofenac and acetylsalicylic acid (ASA) are commonly used in 
mammalian studies as well as in fish as inhibitors of cyclooxygenase-2 (COX-2) activity. 
Consequently, NSAIDs will inhibit the synthesis and release of PGs, which are involved 
in the inflammatory response and also in modulating the functioning of the pituitary-
adrenal axis in humans and fish. To this end, a recent study demonstrated that ASA 
administered in vivo to Mozambique tilapia (Oreochromis mossambicus) disturbed the 
endocrine axes, including attenuated plasma cortisol response to a stressor, leading to the 
proposal that PGs are involved in the stress response process in fish (van Anholt et al., 
Non-steroidal anti-inflammatory drugs (NSAIDS) have been detected in the aquatic 
environment, but little is known about either their impact or mode of action in aquatic 
organisms. We tested the hypothesis that NSAIDs disrupt the evolutionarily conserved 
heat shock response, critical for defense against stressor-mediated proteotoxicity, in 
rainbow trout (Oncorhynchus mykiss). Trout fry were exposed by immersion to a range of 
salicylate or ibuprofen concentrations (1, 10, 100 or 1000 g/L) for 4 days. Ibuprofen, but 
not salicylate, at all concentrations induced heat shock protein 70 (hsp70) in trout liver. 
We used the highest concentration of the drugs to investigate their mode of action on the 
heat shock response.Fry were subjected to a standardized heat shock, 10◦C above ambient 
(13◦C) for 1 hour, and the temporal changes in liver hsp70 mRNA and protein content as 
well as glucose dynamics during recovery from the heat stress or assessed. Ibuprofen 
exposure did not modify hsp70 mRNA abundance, but significantly depressed the heat 
shock-induced hsp70 protein expression in the liver and gill of trout. Salicylate exposure 
elevated hsp70 mRNA abundance and delayed the hsp70 expression after a heat shock. 
Liver glucose levels and the activities of hexokinase, pyruvate kinase and lactate 
dehydrogenase, were elevated by NSAIDs suggesting enhanced tissue glycolytic capacity. 
 
 
Effects on whole body glucose dynamics, induced by the heat shock, were either absent 
with ibuprofen or completely modified by salicylate. Overall, NSAIDs disrupt the heat 
shock response in rainbow trout, while the mode of action of salicylate and ibuprofen in 
impacting the cellular stress response appears distinct. 
 
 
 Figure (2:3) Percentage of published studies on different therapeutic classes, expressed in relative 
percentage, described on 183 articles published between 1996 and 2009.( Sanota et al ., 2010) 
 
 Non-steroidal anti-inflammatory drugs are weak acids acting by reversible or irreversible 
inhibition of one or both isoforms of the cyclooxygenase enzymes, COX-1 and COX-2, 
involved in the synthesis of different prostaglandins from arachidonic acid. A 
cyclooxygenase enzyme similar to human COX-2 has been found in fish thereby making 
them a potential target for aquatic contamination. Prostaglandins also play an important 
role in the synthesis of bird eggshells and from inhibiting its synthesis, shell thinning has 
been observed. Among the NSAID, diclofenac showed the most acute toxic nature with 
effects being observed at concentrations below 100mgL−1. Chronic toxicity trials 
performed on rainbow trout (Oncorhynchus mykiss) evidenced cytological changes in the 
liver, kidneys and gills after 28 days of exposure to just 1 g L−1 of diclofenac. For a 
concentration of 5 g L−1 renal lesions were evident as well as drug bioaccumulation in the 
liver, kidneys, gills and muscle. Brown trout (Salmo trutta f. fario) showed similar 
cytological damage and a reduction of haematocrit values after 21 days of exposure to 0.5 
g L−1 of this active substance. Schmitt-Jansen et al.  Evaluated both diclofenac 
 
 
phytotoxicity and its photochemical products on the unicellular chlorophyte Scenedesmus 
vacuolatus. Inhibition of algal reproduction by the parent compound only occurred at a 
concentration of 23 mgL−1, hence indicating no specific toxicity. However, the threat 
significantly increased when metabolites were produced from 53 h of exposure to daylight.  
 
 
Fig (2:4 ) Therapeutic classes detected in the environment, expressed in relative percentage. Data collected 
from 134 articles published between 1997 and 2009.(Sanota et al ., 2010 ) 
 
Diclofenac also inhibited the growth of marine phytoplankton Dunaliella tertiolecta for 
concentrations of 25mgL−1 and above. For this organism, 96 h EC50 of 185.69mg L−1 was 
found. Diclofenac was detected in STP effluents at maximum concentrations of 2.4 and 
1.42 g L−1 in Switzerland and Belgium respectively which highlighted that the effects 
cited are of sufficient magnitude to suspect chronic toxicity in aquatic organisms. 
Diclofenac has also been found in rivers groundwater, hospital effluents and drinking 
water but at concentrations in the order of ng L−1. Ibuprofen is another NSAID with 
documented chronic toxicity. Female Japanese medaka (the Japanese killifish, Oryzias 
latipes) exposed to different concentrations of the drug over six weeks, showed a sharp 
rise in liver weight together with enhanced egg production, yet with a reduction in the 
number of weekly spawning events. Authors associated these phenomena with changes in 
the spawning process and vitellogenin production, a glycoprotein precursor in yolk 
formation. With the water flea Daphnia magna population growth rate was significantly 
 
 
reduced for concentrations ranging from 0 to 80mg L−1  Reproduction was affected at all 
concentrations and completely inhibited at the highest pharmaceutical levels. An activity 
decrease of the freshwater amphipod Gammarus pulex was noticed when in contact with 
ibuprofen concentrations of 1 and 10 ngL−1, the latter value corresponding to the LOEC 
obtained for behaviour change. Regarding aquatic photosynthetic organisms, specific 
effects have been noticed. A 5-day exposure to concentrations in the 1–1000 gL−1 range 
stimulated the growth of the cyanobacterium Synechocystis sp. while inhibiting that of the 
duckweed plant Lemna minor after 7 days. Ibuprofen has been detected in STP effluents at 
concentrations that can reach 28 g L−1. Two metabolites of ibuprofen (carboxyl-ibuprofen 
and hydroxyl-ibuprofen) were also found in surface waters and in a Swedish STP (influent 
and effluent). Due to demonstrable chronic toxicity, this may represent a real threat to 
non-target organisms, even at those lower concentrations. Ibuprofen was also found in 
rivers and drinking water which may broaden the scope of the problem to public health. 
However, effects in humans caused by chronic exposure to this active substance still 
remain unknown. Acute toxicity tests performed on the rotifer Brachionus calyciflorus, the 
water flea Ceriodaphnia dubia and the fairy shrimp Thamnocephalus platyurus, showed 
that naproxen had LC50 and EC50 values within the 1–100mgL−1 range, with the photolysis 
products being significantly more toxic. Highly chronic toxic properties were equally 
noticed with algae being the less sensitive organisms. Yet again, degradation products 
were shown to be more toxic with EC50 values of 26 and 62g L−1 for C. dubia, relative to 
growth inhibition. Naproxen had been found in STP effluents in a concentration range 
between 31 ngL−1 and 7.96 gL−1 and in surface waters, at concentration levels that can 
reach 250 ngL−1. This active substance was also detected in drinking water. The highly 
prescribed paracetamol (or acetaminophen) is a weak inhibitor of the cyclooxygenase 
enzyme, whose side effects are mainly associated with the formation of hepatotoxic 
metabolites, such as N-acetyl-p-benzoquinone imine (NAPQI) when the levels of liver 
glutathione are low. Tests were carried out on algae, water fleas, fish embryos, 
luminescent bacteria and ciliates. The most sensitive species was shown to be D.magna for 
which EC50 values of 30.1 or 50mgL−1 were reported. Some authors reported the presence 
of paracetamol in STP effluents at concentrations below to 20 ngL−1 to 4.3 gL−1, and in 
surface waters, values can reach 78.17 gL−1, which are values higher than the predicted 
no-effect concentration (PNEC) of 9.2g L−1. Hence, paracetamol might represent a threat 
for non-target organisms. 
 
 
 
 
 
2.7 Study hypothesis:  
 
We hypothesize as a result of these previous studies that the use of cox inhibitors during 
crucial period could modulate aromatase activity and will affect reproduction in 
Niletilapia.  The use of the  NSAID cox inhibitor (non selective cox1, cox 2 Etodolac)  and 
(selective cox2 inhibitor Etoricoxib) would produce an effect on growth rate, mortality rate 
and sex reversal. Also we hypothesized that there is an environmental effect for using 
antiprostaglandin (non selective cox1, cox2 and the selective cox2), especially on  fishes. 
2.8 Study objectives 
The main goal of our study was to predict the effect of Etodolac and Etoricoxib during the 
crucial period of sexual differentiation in Niletilapia where sufficient amount of estrogen 
is needed for proper ovarian development and the suppression of aromatase activity the 
rate limiting enzyme in aromatization of androgens to estrogens leads to sex reversal and 
the arise of male population (Kown et al., 2001). Cyclooxygenase inhibitors suppress 
aromatase expression and activity in breast cancer cells (Diaz-Cruz et al., 2005) and since 
fish posses both COX-1 and COX-2 forms and both are widely expressed during 
development with both isoforms genetically and functionally homologous to their 
mammalian orthologs (Grosser et al., 2002), human and veterinary pharmaceuticals have 
been shown to occur in considerably high amounts in sewage treatment plant (STP) 
effluents and surface waters, with the non steroidal anti inflammatory drugs representing 
one of the most commonly detected compounds Fig(2:4). Information concerning possible 
ecotoxicological risks of these substances is rather scarce. So far there are no data 
available on their possible effects in fish after prolonged exposure. Thus, highlight on 
Etoricoxib pharmacokinetics was carried out by determination of Etoricoxib in fish feces 
using HPLC. 
Specific objectives: 
1- Effect of 0.5% Etodolac and 0.5% Etoricoxib on growth rate of mixed population 
fry tilapia during the crucial period of sexual differentiation. 
2- Effect of 0.5% Etodolac and 0.5% Etoricoxib on growth rate of adult tilapia mixed 
population. 
 
 
3- Effect of increasing concentrations on growth rate. 
4- Mortality and toxicity at different concentrations. 
 
 
 
Chapter Three 
Materials and methods 
 
3.1Experimental system 
The study was carried out at the Aquaculture research laboratory, in AL-Quds University, 
Jerusalem. A warm water recirculation system consisting of a 24 aquaria, with capacity ≈ 
45 L each one was used for the study. Tap water from municipality was used for fish 
rearing. The experimental aquaria were housed indoor. Daily, quarter of the water was 
renewed from each aquarium in order to maintain optimum water quality and better 
hygiene. The flow rate of water  was maintained at 0.5 L l min. All the aquaria were kept 
on 80 –cm  high platform to facilitate better observation and easy maintenance. Water 
temperature was maintained at 28 ± 1 Cº. A constant photoperiod of 12 h light and 12 h 
dark was maintained  throughout the experimental period. The water in the header tank 
was aerated by an air stone and the rates of water flow were adjusted to maintain oxygen 
saturation above 60%. Total nitrogen ammonia was always less than 3mgL−1.The water 
quality parameters in the system were monitored by doing water analysis. Genetically 
mixed population of tilapia fry aged 8 days post- hatched ≈ 400 fry were used in the 
experiment; Commercial feed was used as the control diet. Feed compositions are shown 
in table (3.1). Etodolac and Etoricoxib were purchased from Sigma and Alderich.  
 
 
 
           Table (3:1) Feed Composition and treatment concentrations 
Treatment Composition Concentration 
Control 91.8%DryMatter (OM) 
43.5% Crude protein 
10.9% Crude lipid 
13.0% Crude Ash 
18.7Kj Gross energy 
 
Etodolac  0.5 %, 1 %, 2% 
Etoricoxib  0.5%,   1% 
 
At an age of 8 days post – hatched 30 genetically mixed population of Oreochromis. 
niloticus larvae were stocked in duplicate, into aquariums each with a capacity of ≈ 45L at 
aquatic and aquaculture lab, where the study was conducted. Treatments included 5  
different experimental diet and one standard diet serving as control with two repeats for 
each group from 0.5 % groups of diets. All aquariums in the experiment were 
disconnected from the recirculation system in order to avoid cross- contamination. The test 
diets were prepared by mixing 600 mg of etodolac with 120g,  60 g, 30 g commercial feed, 
to achieve (0.5% etodolac, 1% etodolac, 2% etodolac)  concentration respectively, the 
same process done to the etoricoxib by mixing 90 mg of etoricoxib with 18 g, 9 g, 
commercial feed, also to achieve (0.5%  etoricoxib, 1% etoricoxib)  concentration 
respectively.Feeding started on the same day of stocking and fish were fed once daily. 
Feed was made into pellets crushed into smaller sizes and spread on the water surface 
slowly by hand. Feed was adjusted according to fish weight during the 8th week of the 
experiment when I gave the feed with etodolac and etoricoxib I fed the fish 10 % of their 
weight after this period gives them 5% of their body weight and all diets were changed to 
control diet. 
Fish were weighted every week and counted in each aquarium to determine survival rate 
during 12 weeks period. Individual fish in each aquarium was weighted to the nearest 0.1 
g using a digital scale. The growth rate (GR) was determined using linear regression: yt = 
a + bxt, where yt is the average total weight (g) of the fishes at time t and a is the average 
weight (g) of fishes at the start of the experiment.  
 
 
3.2 Experiments done for fish growth rate: 
1) Experiment number (1): Mixed population of Niletilapia treated with (Etodolac 
0.5%) and (Etoricoxib 0.5%) at age more than 2 month 
There were nine aquarium chosen for the experiment from the recirculatory system after 
separated them from the system to prevent cross contamination. These aquarium were 
divided to three different group, three for standard population without treatment, three 
with (Etodolac0.5%) treatment, and finally the last three for(Etoricoxib 0.5%)  treatment. 
these aquarium were distributed randomly in all side of the system  to achieve the same 
condition for each group. 10 fish were stocked in each aquarium, the diet given to fish in 
each aquarium once daily , amount of diet was 10 % of the fish weight as table (3.2) 
show,every week each aquarium fish were weighed and calculate the 10% amount of diet 
should given to them during the new week. 
2) Experiment number (2) : Mixed population of Niletilapia treated with (Etodolac 
0.5%) and (Etoricoxib 0.5%) at age of 8 days. 
The same procedure done as in experiment one but with duplicate aquarium for each type 
of (etodolac 0.5 %), (etoricoxib 0.5%), and standard.  
30 fry fish were stocked in each aquarium, the fry fish were given 0.1- 0.3 during 8 weeks, 
after this period the fish were weighed and given 10% of their total weight in each 
aquarium as table (3.3) show, three weeks were weight with NSAIDs treatment and 
another three weeks they were weighed without treatment to record the result of growth 
rate if it continuous after stop treatment . 
3) Experiment number (3) : mixed population fry of Niletilapia with concentrations 
of 1% Etodolac, 1%Etoricoxib and 2% Etoricoxib  
In small aquarium 30 fish at age of 8 days post hatch were stocked in 1% concentration of 
etodolac, etoricoxib respectively and standard, 20 fish were stocked for 2% etodolac, only 
one aquarium used for each concentration and they were treated in the same way as the 
previous experiments (1, 2).  
 
 
 
 
 
 
 
 
 
Table (3:2) weight of food given to adult fish every week about 5% of their body 
weight in grams. 
 
** The numbers from ( 1_9) represent the number given to the aquarium in the   
recirculating system 
Table (3:3) weight of food given to small fry fish as 10% of their weight in grams 
*std : abbreviation for standard 
*etd : abbreviation for etodolac 
*eto : abbreviation for etoricoxib 
* (1,2) : aquarium given number 
 
 
 
 
 Std1 Std 6 
 
Std 9 Etd 2 Etd 5 Etd 8 Eto 3 Eto 4 Eto 7  
weeks 1 2.9 2.7 2.9 3  2.9 3.3  3 3 3.8  
weeks 2 3.6 2.9 3.1 3.3 3.4 4 3.5 3.3 4.4 
weeks 3 4.6 3.6 3.8 4 4.2 4.6 4.2 4 5.3 
weeks 4 5.8 4.8 5.1 5.1 5.1 5.7 5.1 4.4 7 
week  5 6.6 5.8 6.1 5.8 6 6.4 5.2 4.2 7.5 
week 6 7.4 6.8 7.1 7.1 7 7.1 6.2 4.4 7.6 
week 7 7.6 8.4 8.5 8.4 8.5 8.1 7.4 5.6 8.6 
week 8 6.3 8.5 11.5 8. 9 8. 8.4 6.8 11.5 
Week Std 0.5% 
       1 
Std 0.5% 
    2 
Eto 0.5% 
    1 
Eto 0.5% 
   2 
Etd 0.5% 
    1 
Etd 0.5% 
   2 
Week 1 1.5 
 
1.3 1.6 1.9 1.7 1.5 
Week 2 2.3 1.9 
 
2.7 2.9 2.8 2.4 
Week 3 3 2.6 
 
4.2 3.1 5 4 
Week 4 4.5 4.3 
 
7.1 5 9 8.3 
Week 5 8.1 7.7 
 
12.5 9.3 16 14 
Week 6 10.5 10.4 
 
15.6 12.1 19.1 17 
 
 
 
 
Table (3:4) weight of food given to fry fish as 10 % of their weight for different 
concentration  in grams . 
 Standard  
 
Etoricoxib  
1%  
Etodolac  
1 % 
Etodolac 
 2% 
Week 1 
 
1.1 1 0.7 0.8 
Week2 
 
1.6 1.4 1.0 1.0 
Week3 
 
1.7 1.7 1.3 1.4 
Week 4  
 
2.2 2 1.9 1.9 
Week 5 
 
3.9 2.8 3.7 3.8 
Week 6 
 
5.4 3.7 5.6 5.4 
 
 
 
Chapter 4  
Results  
 
Table (4:1) Weight of mixed population fish more than 2 month treated with 0.5% 
Etodolac or 0.5% Etoricoxib in grams. 
* The above values  represent the weight of 10 fish in each aquarium . 
As the table (4:1) above show there were no differences in the weight of fish treated with 
Etodolac, Etoricoxib in concentration 0.5% respectively if compare with standard 
aquarium. This result indicate that there is no clear effect for the use of 0.5% NSAIDs 
concentration  for adult fish given food represent 5% of their weight in the aquariums. 
Also about the mortality rate during the experimental period there was no mortality shown 
during  all experimental period  the rate was 0 %, this mean that the survival rate was 100 
% during the 8 weeks of experiment. 
 
 
 
 
 
 
 Std 1 Std 6 Std 9 Etd2 Etd 5 Etd 8 Eto 3 Eto 4 Eto 7 
weeks 1 58 54 58 60 59 67 61 59 76 
weeks 2 72 58 62 65 68 78 70 65 89 
weeks 3 91 72 77 79 84 92 84 78 107 
weeks 4 116 96 102 102 103 115 102 88 141 
week  5 132 116 122 116 120 128 105 85 150 
week 6 148 137 142 143 140 143 125 89 153 
week 7 152 169 170 169 170 162 149 113 172 
 week 8 127 170 231 168 181 165 168 137 230 
 
 
 Table (4:2) Weight of mixed fry population during experiment period   treated with 
0.5% Etodolac or 0.5% Etoricoxib in grams. 
 
 
 
 
 
 
Table (4:3) Average weight of mixed fry fish treated with0.5% Etodolac or 0.5% 
Etoricoxib during experiment period in grams. 
Days std 1 av std 2 av etd 1 etd 2 eto1 av eto 2 av 
1 0.55 0.41 0.51 0.56 0.51 0.61 
7 0.85 0.67 0.82 0.93 0.87 0.93 
14 1.11 0.92 1.44 1.5 1.4 1.06 
21 1.73 1.53 3.07 2.93 2.36 1.37 
35 3 2.75 5.18 5.33 4.13 3.2 
49 3.88 3.96 6.29 6.58 5.2 4.32 
 
As the table (4:2) above shows that the growth rate of fish was higher in the treated 
aquarium in comparison with standard aquarium. 
The growth rate was higher in the aquarium treated with Etodolac, then it followed by 
aquarium treated with etoricoxib in comparison with standard. 
This result show that 0.5% of etodolac or etoricoxib mixed with food have an effect on 
growth rate, and this concentration of NSAIDs increase the rate of growth in compared 
with standard one.  
 
 
 
Days std 1 std 2 etd 1 etd 2 eto 1 eto 2 
1 15 13 17 15 16 19 
7 23 19 28 24 27 29 
14 30 26 45 39 42 31 
21 45 43 88 83 71 40 
35 81 77 160 140 124 93 
49 105 103 191 170 156 121 
 
 
 
 
Figure (4: 1) growth rate of mixed population of Nile tilapia fry during experiment period treatment with 
0.5% etodolac or 0.5% etoricoxib mixed with food 
 
 
 
Figure (4: 2) average growth rate of Niletilapia fry during experiment period in standard aquarium1. 
 
 
 
Figure (4: 3) average growth rate of Niletilapia fry during experiment period in standard  aquariums2. 
 
 
 
 
Figure (4: 4) average growth rate of Niletilapia fry during experiment period in 0.5% Etodolac  aquarium1. 
 
 
Figure (4: 5) average growth rate of Niletilapia fry during experiment period in 0.5% Etodolac aquarium2. 
 
 
 
Figure (4: 6) average growth rate of Niletilapia fry during experiment period in 0.5%Etoricoxib  aquarium1. 
 
 
 
 
 
 
 
 
 
 
Figure (4:7) average growth rate of Nile tilapia fry during experiment period in 0.5% Etoricoxib aquarium2. 
 
 
Growth performance and diet nutrient utilization were analysed in term of percent body 
weight gain (BWG), growth rate, feed conversion ratio, feed conversion efficiency, 
specific growth rate  
BWG = 100* (final body weight –initial body weight) ⁄ initial body weight. 
FCR = the weight of the feed fed to the fish along the study period ⁄ live body  weight 
gain.   
FCE   = fresh body mass gain ⁄the weight of the feed fed to the fish along the study period.  
SGR (%) = 100* [ln (final body weight)-ln (initial body weight)] ⁄ no. of days. 
 
 
 Table (4:4) Body weight gain percentage and other important growth parameters        
  
Result for Experiment (3) 
Table (4:5) Mixed population fish fry weight in small tanks by different 
concentrations of 1%Etodolac, 1%Etoricoxib, and 2% Etodolac in grams. 
days Std  Eto  1% Etd  1% Etd  2% 
1 11 9 7 7 
7 16 14 10 10 
14 17 17 13 14 
21 22 20 19 19 
35 39 28 37 38 
49 54 37 56 54 
 
 BWG (in gram) FCR FCE SGR % 
Standard 1 600 0.333 3.00 3.97 
Standard 2 692 0.312 3.20 4.22 
Etodolac 1 1023 0.304 3.28 4.93 
Etodolac 2 1033 0.303 3.29 4.95 
Etoricoxib 1 875 0.311 3.211 4.64 
Etoricoxib 2 536 0.326 3.06 3.77 
 
 
Table (4:6) Average Weight of fish fry treated with different concentrations of 
1%Etodolac, 1%Etoricoxib, and 2% Etodolac in grams. 
days Std Eto  1% Etd  1 % Etd  2% 
1 0.36 0.3 0.25 0.43 
7 0.53 0.46 0.4 0.62 
14 0.56 0.6 0.54 0.87 
21 0.75 0.76 0.86 1.35 
35 1.39 1.33 1.68 3.45 
49 2 1.7 2.66 5.4 
 
 
Figure (4: 8) growth rate of mixed population Niletilapia  fry during experiment period  treatment with 
1%Etodolac,1%Etoricoxib , 2% Etodolac mixed with food 
 
 
 
 
Figure (4: 9) average growth rate of Niletilapia fry during experiment period in standard aquarium 
 
   Figure (4:10) average growth rate of Niletilapia fry during experiment period in 1% Etoricoxib   aquarium 
 
 
 
 
Figure (4:11) average growth rate of Niletilapia fry during experiment period in 1% Etodolac aquarium. 
 
 
Figure (4:12) average growth rate of Nile tilapia fry during experiment period in 2% Etodolac aquarium. 
 
The different concentration affect the growth rate in a dose- dependent manner.This 
appears with the weight of fish treated with Etodolac in compared with Etoricoxib or 
Standard. The highest growth rate was in the aquarium treated with Etodolac at 2% 
concentration followed by Etodolac 1% concentration followed by standard.  Etoricoxib at 
1% was toxic with decreased growth rate compared to standard.  
 
 
Table (4:7) percentage of survival rate and mortality rate during the second  
experiment. 
Week Standard 
- 
1 
Standard 
- 
2 
Etoricoxib 
0.5% 
1 
Etoricoxib 
0.5% 
2 
Etodolac 
0.5% 
1 
Etodolac 
0.5% 
2 
Week 1 27 30 30 30 30 29 
Week 2 27 28 30 30 30 29 
Week 3 27 27 29 28 30 27 
Week 4 26 27 29 28 30 27 
Week 5 26 27 29 28 30 27 
Week 6 26 25 29 27 29 27 
Survival rate 86.6% 83.3% 96.6% 90% 96.6% 90% 
Mortality rate 13.4% 16.7% 3.4% 10% 3.4% 10% 
 
 
Table (4:8) percentage of survival rate and mortality rate for treatment with 
different concentrations of Etoricoxib 1%, Etodolac1%, and Etodolac2%. 
Week standard Etoricoxib 1% Etodolac 1% Etodolac 2% 
Week 1 30 30 27 16 
Week 2 30 30 25 16 
Week 3 30 28 24 16 
Week 4 29 26 22 14 
Week 5 28 21 22 11 
Week 6 27 19 21 10 
Survival rate 90% 63% 70% 50% 
Mortality rate 10% 37% 30% 50% 
 
 
 
 
 
Chapter Five  
Discussion 
5.1 Growth Performance Parameters        
The different growth rate parameters (final body weight, weight gain and  growth rate (GR) of 
O niloticus fed with Etodolac (non-selective COX-1 inhibitor with preferential COX-2 
selectivity) and Etoricoxib (selective COX-2 inhibitor) respectively shown in table (4:2,4:3) 
Figs (4.1__4.7) were significantly affected by NSAIDs administration with Nile tilapia diet, 
with the highest growth (final weight, weight gain and GR) table(4:3) obtained with the 0.5% 
Etodolac followed by Etoricoxib 0.5% followed by untreated sample. These results indicate 
that the inclusion of selective COX-2 inhibitors in fish diet may be beneficial for fish growth. 
Etodolac, in humans, is reported to cause a gradual weight gain attributed to the effect of 
medication itself or due to its effect on other factors (Boullata and Armenti., 2004). The increase 
in fish growth may be because of that NSAIDs modulated gastrointestinal blood flow and 
increased the proteolytic activity of the gut inducing the feed digestion and absorption rate 
causing increase in body weight (Rust., 2002). The gastrointestinal (GI) tract of most teleost 
species studied to date is, in contrast to most mammalian species, supplied mainly via one 
major vessel, the coeliacomesenteric artery (CMA), which branches off the dorsal aorta. The 
CMA then divides into two major arteries, the larger intestinal artery (also often referred to as 
the mesenteric artery) and the smaller gastric artery (coeliac artery), about 10-40% of CO 
reaches the GI tract in unfed fish, (Axelsson et al., 1989; Dupont-Prinet et al., 2009). However, 
after feeding over 50% of CO reaches the GI circulation (Axelsson and Fritsche, 1991).   For 
example the increase in GBF after the ingestion of a normal sized meal ranges from around 
70% in the sea bass (Dicentrarchus labrax) (Axelsson et al.,2002) to over 150% in the sea bass 
and the rainbow trout (Dupont-Prinet et al., 2009; Grans et al., 2009).  An increase in the blood 
available to the GI tract after feeding can be achieved either through an increase in the blood 
volume pumped by the heart per time unit (i.e. cardiac output; CO) and/or a redistribution of 
blood to the GI circulation from other systemic vascular beds without a concomitant increase in 
CO. The relative contribution of each factor is strongly influenced by the physical status of the 
animal (i.e. exercise or other stressors) as well as the environmental factors such as oxygen 
availability. Consequently, the postprandial increase in Gastric blood flow will depend on both 
 
 
the decrease in resistance of the GI vasculature, i.e. the hyperemia, and how much blood that is 
available to the GI tract, either by an increase in Cardiac output or a redistribution of blood. In 
contrast to what happens postprandially in mammals such as dogs, where there is a limited 
increase in the CO after feeding in a stationary dog, thus, the increase in GBF is therefore 
almost entirely due to a redistribution of blood. There is a shift in the amount of CO reaching 
the GI vasculature in fish, which is mediated via a decrease in the resistance of the GI 
vasculature and a maintained or increased resistance of other systemic vascular beds.  
However, if the animal goes from being stationary to being more active there is in general also 
an increase in cardiac output in order to maintain the postprandial increase in GBF in dogs 
(Gallavan et al., 1980). On the other hand, the vascular endothelial cells play a central role in 
synthesizing and releasing prostaglandins, which may have constricting as well as relaxing 
effects on blood vessels. Following their intracellular synthesis, prostaglandins probably exit 
the cell by facilitated diffusion and affect the parent cell and/or neighboring cells in an 
autocrine /paracrine manner. They act through specific G-protein-linked prostanoid receptors, 
altering levels of different second messengers (Smith., 1992). Prostaglandins have diverse 
effects in fish circulation, and are likely to serve a multitude of functions (Janvier1997., Brown 
and and Bucknall1985; Sundin and Nilsson., 1998). PGF2 is involved in a haemostatic 
vasoconstriction and may take part in the control of brachial circulation, by constricting 
filament arteries. In contrast, PGE2 has most of its effect on the heart. PGE2 causes a reduction 
in cardiac output with a decrease in systemic resistance and increase in gills vascular 
resistance. It also reduces dorsal aortic blood pressure (Stenslokken et al.,2002). 
After the meal had been digested i.e. Enzymatically broken down into smaller components by 
carbohydrases, lipases and proteases (Kitamikado and Tachino., 1960a, b, c). It is likely that it 
is these hydrolyzed products that induce the subsequent GI hyperemia and mechanical 
distension of the stomach elicits an increased adrenergic tone on the systemic vasculature, 
producing a vasoconstriction in the systemic circulation including the GI portion, and a 
subsequent increase in dorsal aortic pressure. This leads to either a redistribution of blood flow 
from the systemic circulation or a larger fraction of the cardiac output reaching the GI tract in 
the event that cardiac output increases. This pressor response increases the driving force for the 
perfusion of the GI vasculature when chemical stimuli (hyperemia) induce a decrease in the 
resistance of the GI vasculature mediated via hormones like cholecystokinin (CCK),(Seth et 
al., 2009,2010). The circulating level of CCK is also influenced by the diet (Jonsson et al., 
2006). NSAIDs may enhance the proteolytic activity of the gut by increasing proteases activity 
 
 
(Rust., 2002), thus accelerating the hyperemia event (Seth., 2010). In addition, blocking 
prostaglandins synthesis abolishes there effect previously mentioned on the heart. Further more 
acidic water from, accumulation of these drugs in a closed system could act as a stressor that 
activate catecholamine release which have additional  stimulatory  effects  on cardiac  output 
(Randall and Perry.,1992).Growth  is  under  multiple  endocrine  control,  with growth  
hormone  as  the  pivotal  factor.  Insulin,  thyroid  hormone,  and  gonadal  steroids,  in  
particular  during  the  initial phases  of  sexual  maturation,  also  have  growth-promoting 
capacities in teleost fish (Pickering.,1990). The maintenance of adequate thyroid status in fish 
is a prerequisite for normal growth. Thyroid hormones are thought to play a permissive role in 
the growth process, potentiating the effects of other anabolic hormones, most notably growth 
hormone. The main actions of TH in fish appear to involve regulation of growth, early 
development, metamorphosis and aspects of reproduction (Brown et al., 2004). The thyroid 
tissue in most teleosts is scattered diffusely in the basibranchial region but, as in other 
vertebrates, consists of follicles formed of a single layer of epithelial cell surrounding an 
extracellular lumen containing proteinaceous colloid. Unlike mammals, the fish thyroid 
cascade can be broken down into three elements. First is the centrally controlled brain-
pituitary-thyroid axis, responsible for synthesis, storage, and secretion of T4 and maintenance 
of T4 levels for a given physiological state (central control).  The second element is the 
peripherally controlled (e.g., in liver tissue) availability of the active hormone T3 via outer-ring 
monodeiodination of T4, which occurs in peripheral tissues (e.g., liver tissue). The third phase 
is the receptor-mediated effects of T3 on target cells to regulate development, growth, and 
aspects of reproduction (Eales and Brown., 1993). While similarities exist between mammalian 
and fish thyroidal systems, the fish thyroidal system does not appear to be centrally driven (i.e., 
via brain-pituitary-.thyroid axis) but instead is under peripheral control. The type I deiodinase 
(D1), which is capable of both activation (outer-ring deiodination (ORD) and inactivation 
(inner-ring deiodination (IRD),   (Sanders et al., 1997)  . However, the type II deiodinase (D2) 
only has ORD activity and deiodinase (D3) capable only of IRD (Sanders et al., 1999;Orozco 
et al., 2003).Thyroid status itself is one of the most potent regulators of iodothyronine 
deiodinase expression. The study by (Molka et al.,1999) showed that in the Nile tilapia, 
induction of hyperthyroidism by feeding the animals with T3-supplemented food (12 ppm) for 
11 days resulted in a prominent decrease in hepatic D2 activity, where as hepatic D3 activity 
increased. However, neither brain nor gill D3 activity was affected, nor was kidney D1 activity. 
On the other hand induction of hypothyroidism by providing fish food containing 0.2% 
methimazole for 11 days increased liver type II deiodinase (D2) with no changes in kidney 
 
 
type I deiodinase(D1), and resulted in a significant decrease in brain, gill and liver type III 
deiodinase (D3). Other studies demonstrated that the hepatic D1activity, as well as D1 mRNA 
expression, is up regulated in hypothyroid tilapia, (VanderGeyten et al., 2001). Numerous 
chemicals can modify vertebrate thyroid function. They range from complex synthetic 
halogenated or phosphorylated hydrocarbons to simple cations or anions (Brown et al, 2004). 
Several pharmaceuticals, discharged mainly in untreated or treated sewage, have the potential 
to influence the fish thyroid. Iodinated radiologic contrast agents that contain a triiodo- and a 
monoamino-benzene ring with a propionic acid chain (e.g., iopanoic acid, iopodate used for 
oral cholecystography) are potent antagonists of peripheral deiodinating activity in mammals, 
Iodinated diagnostic contrast agents like iopromide and diatrizoate are resistant to 
transformation during sewage treatment and can be found in effluent-dominated rivers at mg/l 
levels. Though these agents have a low acute toxicity to fish, their chronic impacts have not 
been investigated. In rainbow trout, i.p.-injected ipodate at 5 mg/100 g depressed plasma T3 
levels, T4 monodeiodination and plasma clearance of both T4 and T3, and reduced the hepatic 
nuclear T3 receptor maximum binding capacity. Iopanoic acid also has been used to induce a 
hypothyroid state in brown trout and C. batrachus. Several other pharmaceuticals influence the 
following steps in the thyroid cascade : Active  transport of I2 (complex anions—perchlorate, 
fluoroborate, pertechnetate), iodination of TG (thionamides—propylthiouracil, methimazole, 
carbimazole; aniline derivatives; sulfonamides), DIT coupling reaction (thionamides; 
sulfonamides); TH release (lithium salts) ;peripheral deiodination (thiouracil, amiodarone, 
hormone excretion and inactivation through competition for TH binding sites to plasma 
proteins or induction of hepatic drug-metabolizing enzymes (salicylates, clofibrate, methadone, 
5-fluorouracil, mefenamic acid, furosemide, Phenobarbital, rifampin, carbamazepine, 
phenytoin, hormone action (TH analogs, amiodarone and phenytoin) and TH binding in the gut 
lumen (cholestyramine, Cyclooxygenase (COX) inhibitors, such as the methylated indole and 
indomethacin, block the synthesis of prostaglandins that contribute to regulation of cell growth 
in the mammalian thyroid gland, and indomethacin can alter cell growth in thyroid cancers 
(Frenkian, et al, 2001). Numerous types of other anti-inflammatory COX inhibitors (e.g., 
ibuprofenb, naproxen, rofecoxib, and celcoxib, are now prescribed but no reports found for 
their effects on thyroid function in any vertebrate. In humans, salicylates inhibit the binding of 
T4 to all plasma transport proteins, resulting in a decrease in T4 and a transient increase in fT4. 
With sustained use, these agents cause a 20% to 40% decrease in T4 concentrations but do not 
alter fT4 .Other studies of various NSAIDs (e.g., oxaprozin, ketoprofen, etodolac) given at 
therapeutic doses for more than 3 weeks demonstrated no change in T4 concentrations, but 
 
 
ketoprofen and nabumetone caused a decrease in serum T3 concentration(Carlson.,1999). Data 
on NSAIDs are limited in dogs, but carprofen (2.2 to 3.3 mg/kg PO q12h) given for 5 weeks 
resulted in a small but statistically significant decrease in T4 (20.8 to 17.0 nmol/l) and TSH 
(0.16 to 0.12 ng/ml) concentrations without altering serum fT4 (Ferguson et al., 1999).Also, 
Serum total T4 concentrations decreased significantly within 24 hours of receiving aspirin with 
no significant changes in thyroid function associated with ketoprofen administration (Daminet 
et al., 2003). In another study thirty eight dogs that were treated, for orthopedic disorders were 
given etodolac (10 to 13.3 mg/kg, orally, once daily) for14 days, serum T4 concentration 
decreased significantly after etodolac administration with increased cTSH. Serum free T4 
concentration was not significantly affected (Ness et al., 2003). PGs are known to influence a 
wide range of physiological processes by enhancing the release of hormones and altering the 
sensitivity of target organs (Lands., 1991; Mustafa and Srivastava, 1989). (Langer et al., 1978) 
found that ASA treatment reduced plasma levels of TSH, T3, and T4 in humans, which 
indicated the involvement of PGs in the release of thyroid hormones. Studies on mammals 
further showed that PGs enhanced the response of thyroid tissue to TSH, resulting in higher T3 
and T4 levels ( Lands., 1991). Basal levels of T3 were also significantly reduced in tilapia after 
ASA treatment, suggesting that PGs have a similar regulatory function (van Anholt et al., 
2003). According to our literature review we propose that Etodolac and Etoricoxib could 
induce a hypothyroid state in tilapia. Since the thyroid cascade may respond indirectly and it 
has considerable capacity to compensate for abuses that otherwise would disrupt thyroid 
hormone homeostasis, it up regulates peripheral deiodinase enzymes as mentioned previously. 
In addition inhibition of plasma protein binding has increased f T4 and f T3. Less than 1% of 
plasma total T4 (TT4) is free (FT4) with 99% reversibly bound to plasma proteins. Plasma FT4 
has a strong negative feedback action on the brain–pituitary–thyroid axis aggravating the 
hypothyroid state. Although the proportion of total T3 (TT3) that is free in plasma (FT3) is 
usually less than that for T4, the T3 binds also to some plasma proteins that bind T4.Thus 
further investigations by conducting a deiodination assay along with the measurement of 
plasma T4 and T3 levels should provide a good indication of the peripheral thyroid system 
status.  
Results showed no increase or decrease of growth in mixed population adult Nile tilapia treated 
with 0.5% Etodolac and 0.5% Etoricoxib (Table 4:1). This result reflects the fact that growth is 
regulated by several controls including differences in levels of both sex- related hormones and 
metabolic hormones, with growth hormone having a pivotal role. Thyroid hormones and 
 
 
gonadal steroids are important In particular during the initial phase of sexual maturation and 
development (Pickering., 1990). Thyroid hormones assist in control of osmoregulation, 
metabolism, somatic growth, development, and posthatching metamorphosis (Janz., 2000). 
Metamorphosis in flounder and flatfish eye, mouth, and neural structures is associated with a 
dramatic spike in thyroxine (T4) concentrations (Janz., 2000). These results support our 
hypothesis that COX-inhibitors could modulate aromatase enzyme during the crucial period of 
sexual differentiation as we will discuss later.  In addition deiodination activity in fish is 
responsive to many environmental and physiological conditions (e.g., food quantity, food 
quality, pH, salinity, turbidity) (Eales et al., 1999). Tilapia kept in partially closed systems and 
fed artificial diets have been reported to have a decreased growth after a certain period of time. 
This may be due to the fact that tilapia needs a continuous supply of their natural food or 
because of a build-up of growth inhibiting factors in the system (Jackson et al., 1982). 
The main goal of our study was to predict the effect of etodolac and Etoricoxib during the 
crucial period of sexual differentiation where sufficient amount of estrogen is needed for 
proper ovarian development and the suppression of aromatase activity the rate limiting enzyme 
in aromatization of androgens to estrogens leads to sex reversal and the arise of male 
population (Kown et al., 2001). It is well known that there are differences in male vs female 
growth rates in Oreochromis species.Monosex production or even incomplete female prevents 
reproduction and therefore feed energy could be diverted into growth instead of production of 
unwanted juvenile fish. Brueggemeier et al. (1999) pointed to linear dependence between 
aromatase gene (CYP 19) expression and expression of COX-2 in mammary carcinoma. The 
above mentioned facts predetermine the use of NSAIDs in mammary carcinogenesis 
prevention. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast 
cancer cells (Diaz-Cruz et al 2005) and since fish posses both COX-1 and COX-2 forms and 
both are widely expressed during development with both isoforms genetically and functionally 
homologous to their mammalian orthologs (Grosser et al., 2002), we tested the hypothesis of 
possible cyclooxygenase inhibition during the crucial period that may modulate aromatase 
activity, thus altering sexual differentiation. Our observation of significant differences in 
growth rates of mixed fry Nile tilapia (table 4:2,4:3) compared to adult mixed population 
table(4:1) following  exposure  to 0.5% Etodolac and0.5% Etoricoxib at  this  early  stage  
indicates that:  Cox inhibitors could alter aromatase activity needed  for proper sexual 
development and reproduction as mentioned earlier. An earlier study conducted in our lab 
showed no significant differences in growth rate (GR) of 20 genetically females (XX) (O.  
 
 
niloticus) fry following treatment with 1%diclofenac, 5%diclofenac, and 5%ibuprofen.  The 
results were 36%, 17% and 22% of the fish never produced egg in the 1% diclofenac group, 
0.5% ibuprofen group, and 0.5% diclofenac group respectively during the entire experimental 
period. Macroscopically all the non-spawning fish in the experimental groups were females 
with apparently larger ovaries and full of eggs compared to control. Microscopically they were 
full of apparently normal eggs with morphology similar to those of control (Al-Qutob2009). 
Previous studies also showed that Ibuprofen in the ranges of (1-100  ugL-1)  decreased  the 
number of spawning events and increased the number of eggs per reproductive cycle in adult 
Japanese medaka (Flippin  et al., 2007). 
 We propose that alteration of aromatase activity at the transcriptional level by the COX-
inhibitors decreases the rate of aromatization which alters E2 (estrogen) levels. Low (E2) 
release the feedback inhibition on gonadotropins producing high FSH levels that inhibits 
ovulation, since it is present in the blood of immature fish and levels increase during the 
vitellogenic phase but should decline towards follicular maturation and spawning (Kawauchi et 
al., 1989). FSH is aheterodimeric glycoprotein synthesized and secreted by the anterior 
pituitary gland. This hormone is involved in the regulation of essential vertebrate reproductive 
processes such as gametogenesis and follicular growth. They are composed of a common a 
subunit and a unique b subunit that confer biological specificity to each hormone (Pierce et al., 
1981). These glycoprotein hormones are structurally and functionally conserved in various 
vertebrates and have been identified in most lineages of action pterygian (bony) fish (Park et 
al., 2005). cDNA sequences encoding gonadotropin subunits have been isolated and 
characterized from more than 19 fish species, including tilapia (Yaron et al., 2001). The two 
gonadotropins, LH and FSH, are synthesized by two different cell types in the pituitary of 
tilapia, and have distinct temporal expression and release profiles (Yaron et al., 2001). In most 
fish, FSH is generally prevalent during early gonadal development and the vitellogenic phase, 
while LH secretion remains at low levels during these phases and exhibits a sharp peak around 
final oocyte maturation and ovulation or during spermiation (Yaron et al., 2003). FSH release 
in female tilapia is under the control of the hypothalamic decapeptide GnRH and the feedback 
inhibition loop at the gonadal-pituitary-axis (Aizen et al., 2007; Yaron et al., 2003). This 
contrast with the situation in mammals in which most of the FSH secretion occurs is dependent 
of signals arising from the GnRH receptor to the release mechanisms (Pawson and McNeilly., 
2005).   It was found that recombinant tFSH significantly enhanced 11-ketotestoster-one (11-
KT) and estradiol secretion from tilapia testes and ovaries, respectively, in a dose-dependent 
 
 
manner (similar to tilapia pituitary extract, affinity-purified pituitary FSH, and porcine FSH 
(Aizen et al., 2007) The somatic growth of teleosts is controlled by the growth axis consisted of 
hypothalamus–pituitary–liver, i.e.The GH/IGF-I axis. GH released from the pituitary gland 
binds to its receptor and stimulates insulin-like growth factor-I (IGF-I) synthesis and secretion 
from the liver and other sites, evoking biological actions through IGF receptors (Butler and 
LeRoith., 2001). However, the modulation patterns in the axis are not a basic point to point 
linear regulation and feedback, but rather are a kind of multifactorial and multiregulational 
manner, which makes up a regulation network of GH synthesis and secretion in fish. In the 
hypothalamus, a number of neuro endocrine factors directly act on somatotropes, including 
pituitary adenylate cyclase-activating peptide (PACAP), GH-releasing hormone (GHRH), 
gonadotropin-releasing hormone (GnRH), Neuropeptide Y (NPY), somatostatin (SS). In 
addition, these neuroendocrine factors have interactions controlling GH secretion and are also 
affected by some of the peripheral factors. Gonadotropin (GtH) released from the anterior 
pituitary regulating reproductive functions, interacts with GH at multiple levels to respectively 
modulate the functions of the gonadotrophic and somatotrophic axes. In mammals, at the 
pituitary level, transcripts of GH receptors and GH-binding sites are observed to appear in 
gonadotrophs, and the stimulatory actions of GnRH on LH and FSH release are inhibited by 
GH immune neutralization, suggesting that endogenous GH may act in a para-crine manner 
regulating gonadotroph functions. Similarily, GH release is also under the influence of the 
gonadotrophic axis, especially via the release of sex steroids.In fact according to our 
hypothesis which is previously stated the high FSH could increase growth hormone secretion 
by somatotrophs. (Zhou  et al.,2004) proposed a novel mechanism regulating GH release and 
synthesis in fish where by the local interactions between gonadotrophs and somatotrophs may 
form an intrapituitary feedback loop for regulating GH release and synthesis. In this model, 
GTH released from gonadotrophs induces GH release and GH production in neighboring 
somatotrophs. GH secretion maintains somatotroph sensitivity to GtH stimulation, and 
simultaneously, inhibits basal GtH release in gonadotrophs. In tilapia, the somatotrophs are 
located in the proximal pars distalis (PPD) forming a palisade around the nerve ramifications; 
the gonadotropin (GtH) I (FSH-like) gonadotrophs are adjacent but slightly peripheral to them, 
where as the GtH II(LH-like) gonadotrophs outlay these cells (Melamed et al.,1998). Paracrine 
interactions also exist between the gonadotrophs and somatotrophs in the tilapia pituitary 
(Melamed et al., 1999). No direct effects of gonadal steroids on expression of the tilapia GH 
gene were reported. Although they did appear to increase the sensitivity of the somatotrophs to 
some of the hypothalamic GH-releasing hormones. The effects of testosterone could be 
 
 
mimicked by estradiol (E2), but not the non aromatizable 11-ketotesoterone, as the testosterone 
is aroma-tized before eliciting these effects (Melamed et al., 1995; Melamed et al., 1997).  It is 
also worth to mention that the thyroid axis (TRH, TSH, and T3) stimulates both synthesis and 
release of GH in tilapia (Melamed et al., 1995), thus interfering with this axis could indirectly 
alter GH secretion. 
 Studies showed that many endocrine disruptive chemicals could alter aromatase Cyp19 
expression or activity at both transcriptional  and  post  transcriptional  levels  and this is 
evident by the presence of multiple transcriptional regulatory elements which include cyclic 
adenosine monophosphate  (cAMP)  responsive  elements,  a  steroidogentic factor 1/adrenal 4 
binding protein site, an estrogen  responsive  elements  (ERE),  half-ERE'S, dioxin-responsive 
element and elements related to diverse other nuclear receptors and the cAMP responsive 
elements (CREs) were predicted in the 5-flanking  regions  of both cyp19a and cyp19b genes in 
teleosts (Cheshenko et al., 2008).  cAMP responsive element binding protein (CREB) regulates 
the transcription upon activation by phosphorylation with protein kinase A upon elevation of 
intracellular cAMP levels. Around 300 different stimuli can provoke CREB phosohorylation 
(Johannessen et al 2004). The use of NSAIDs like Etodolac(non-selective COX-1 inhibitor 
with preferential COX-2 selectivity) and Etoricoxib(COX-2 inhibitor) inhibit the production of 
prostaglandins  (PGs) and  lowers  intracellular, cAMP, which could result in decreased 
aromatase expression via  affecting  promoter  through  cAMP responsive elements (CRE) at 
the transcriptional level. In addition, prostaglandin metabolites have also been shown to 
activate transcriptional targets directly in mammals, by binding  to peroxisome proliferative-
activated receptors (PPARs) which are members of orphan nuclear superfamily, that 
constitutively bind to the promoter elements of their target genes (Forman et al., 1997). PPARs 
super family was identified in tilapia (Chang et al., 2005). Other possible postulated 
mechanisms  could  be  through  free  ArA  (arachidonic acid) generated by blocking the 
cyclooxygenase pathway (COX-1 and COX-2), which can modulate mRNA cyp19 expression 
by altering the binding of estrogen to its estrogen receptor elements (ERE) thus down 
regulating cyp19 expression, indeed estrogen will not be synthesized in sufficient amount, or it 
can modulate cyp19 activity at the post transcriptional levels by competing with the substrate 
for binding to active site of the enzyme. Endogenous long chain fatty acids are known to be 
regulators of cell signaling pathways and to affect either positively or negatively the binding of 
steroid hormones to their specific plasma proteins and their specific intracellular receptors and 
have also shown to co-regulate glucocorticoid-dependent gene expression (Sumida ., 1995).  
 
 
PPARs family members exhibit also a strong binding affinity for both saturated and 
unsaturated fatty acids which may indicate that the increase  in free arachidonic (ArA) from 
cyclooxygenase inhibition could have an inhibitory effect on aromatase though binding to 
PPARs receptors (Mu  et al.,  2001). 
Ovarian follicular development lies with the interaction between pituitary gonadotropins, 
follicle stimulating hormone and luteinizing hormone (and glucocorticoid hormone and 
prolactin in some species), and intraovarian factors such as steroid, cytokines and other growth 
factors. Among these, prostaglandins (PGs) possess vasoactive, mitogenic, and differentiating 
properties and are implicated in various female reproductive functions. In particular, PGs have 
been shown to play key roles in ovarian physiology, the periovulatory period, and female 
reproduction. Several studies have suggested a role for PGs in the maintenance and function of 
the cumulus–oocyte complex (COC). PGE2 was one of the earliest substances shown to induce 
cumulus expansion in vitro. Additionally, COCs obtained from rats and mice after 
superovulation synthesize PGE1, PGE2 and PGF2α. Therefore, any drug that blocks synthesis 
of PGs would affect female reproductive function. In fact, it is reported that high doses of 
indomethacin (an inhibitor of both cyclooxygenase-1 (COX-1) and -2 (COX-2), one of the 
nonsteroidal anti-inflammatory drugs NSAIDs or a “specific” COX-2 inhibitor (NS-398) can 
block ovulation in rats. In addition, treatment of COCs with indomethacin greatly reduces the 
in vitro fertilization rate of oocytes, and this effect is reversed if PGE1 and PGE2 are added to 
the media in the presence of indomethacin. These data suggest that PGs may be critical for 
maintaining an optimal microenvironment for oocyte survival and fertilization. However, 
although use of low-dose indomethacin can abolish ovarian PGE2 synthesis, low-dose 
indomethacin failed to affect ovulation. In contrast, high-dose indomethacin resulted in 
significant inhibition of ovulation. It was also noted that absence of COX-2 in mice led to 
defects in ovulation, fertilization, and implantation, suggesting that COX-2 enzyme may play 
an important role in female reproduction. Selective COX-2 inhibitors are commonly used in 
clinical practice, including for the management of dysmenorrheal, menorrhagia or other 
rheumatism, all of which often attack women in reproductive age. In this study, a low dose of 
the selective NSAID COX-2 inhibitor, celecoxib, was used to evaluate its effects on the 
reproductive function of female mice. COX-2 inhibitor may be safe if the dose is low because 
we clearly demonstrated that low-dose COX-2 inhibitor of ≤ 5 mg/kg celecoxib per day did not 
seem to affect the normal fertility of female mice, suggesting that implantation may not be 
impaired when using a low dose of COX-2 inhibitor. Since differences exist between primates 
 
 
and other species in the sites and timing of COX-2 expression in the ovary, COX-2 inhibitors 
may produce different results in these species. In addition, emerging evidence shows that 
COX-2 inhibitors may impair fertilization, implantation, and maintenance of pregnancy. From 
this study, we found that low-dose COX-2 inhibitor did not affect fertilization, implantation 
and maintenance of pregnancy in a mouse model. Overall, the therapeutic window between 
pain relief and fertility impairment in using COX-2 inhibitors in clinical practice is worthy of 
further investigation (Elvin et al., 2000; Findlay et al., 2002; Dey et al., 2004). 
5.2 Mortality vs Toxicity: 
In reference to tables (4:5,4:6), there were no differences  in mortality rates between 
(0.5%Etodolac),and (0.5%Etoricoxib) treatments, but survival rate (96.6% and 90%) was 
improved compared to control (86.6%,83.3%) during the experimental feeding. Higher 
mortalities were shown as concentrations increase with (1%Etoricoxib), (1% Etodolac) and 
(2% Etodolac) table (4:6) treatments. Improved survival could reflect the anti inflammatory 
effect of COXs inhibitors. One could expect that use of NSAIDs is associated with lower levels 
of inflammatory markers. NSAIDs are documented to be used by athletes as an ergogenic aid 
to enhance performance especially before and during long endurance races and longer training 
sessions. The theory behind this practice is that the prophylactic inhibition of the production of 
inflammatory mediators will lead to decreased muscle soreness, fatigue, and ultimately shorter 
recovery times and improved performance. However, currently there is no convincing evidence 
that NSAIDs enhance performance or recovery time (Nieman et al., 2006; Donnelly et al., 
1990). (McAnulty et al., 2007) studied the effects of inflammatory markers in a group of 
ultramarathon ibuprofen “users” versus “non-users”. He found that some inflammatory 
markers were actually increased in the ibuprofen user vs. the non-user group. In another study, 
the use of NSAIDs was associated with lower levels of IL-6 and higher levels of TNF-a but 
was not associated with CRP levels (Il’yasova et al., 2005).Mortality rates for (0.5%Etodolac), 
and (0.5%Etoricoxib)  were comparable to (0.5% Ibuprofen, and significantly lower than (0.5% 
diclofenac) reported in a previous study (Al Qutob.,2009). So far, there are no data available on 
the chronic toxicity of Etodolac, and Etoricoxib to fish. Previous studies with Ibuprofen 
showed its toxicity on aquatic organism  Daphnia magna, and the mollusk Planorbis carinatis 
(Pounds et al.,2008) which had been reported  to be in mgL-1 range.Other study carried on 
adult Japanese Medaka,  Oryzias  latipes showing that exposure to nominal concentrations of 
ibuprofen in the range of (1-100ugL-1) for 6 weeks altered reproduction with no evident 
 
 
pathological damage in the gills, liver and kidneys of fish from the highest exposure group 
(Flippin  et  al.,2007). In contrast, investigations of (Schwaiger et al., 2004) of diclofenac 
toxicity on rainbow trout revealed that the lowest observed  effect concentration (LOEC) at 
which both renal lesions and alteration of gills occurs is 5 ugL-1with concentration related 
accumulation of the drug in all organ examined, and the highest amount detected in liver, 
followed by kidney, gills and muscle  tissue.  
Although increasing drugs concentrations increased mortality table (4:6),the different 
concentrations as shown in table(4:5,4.6) and figures (4:8__4:12),affected the growth rate in a 
concentration dependent manner. This appears with the weight of fish treated with Etodolac 
and Etoricoxib compared to standard. The highest growth rate was in the aquarium treated with 
(2% Etodolac) followed by (1% Etodolac). (1% Etoricoxib) showed a decreased growth rate 
compared to standard which could indicates a toxic potential of Etoricoxib toward fish at this 
concentration. In addition growth rate with 0.5% Etodolac(0.131 and 0.136) was higher than 
with increasing concentrations of  Etodolac that show growth rate of (0.05) with 1% Etodolac 
and (0.107) with 2% Etodolac respectively. These facts could be considered as sign of toxicity. 
Under controlled experimental factors we should take into consideration the altered 
physiological effects mediated by the inhibition of prostaglandins (PG) synthesis. Gills 
alterations may interfere with normal respiratory functions and renal changes might lead to 
impaired osmoregulation (Evans et al 2004). Furthermore prostaglandins are involved in many 
physiological functions eghomeostasis and nervous system function (Mustafa & Srivastava., 
1989) of which blocking could enhances the non-specific toxic effects. In the kidneys of 
mammals, cyclooxygenase type 2 (COX-2) is expressed in medullary interstitial cells, the 
macula densa and epithelial cells of the cortical thick ascending limb where it generates 
prostaglandins that regulate hormone secretion, inhibit ion transport, and support cell survival 
during salt loading and dehydration (Harris and Breyer., 2001). Gills are primary site of 
osmoregulation in fishes and contains specialized cells that secrete NaCl (chloride cells)  via a 
mechanism that is similar to the NaCl transport mechanism of shark rectal glands and the 
mammalian cortical thick ascending limb of the kidney (Evans et al., 2005). Prostaglandins 
inhibit short circuit currents (Isc) that are a result of active Cl secretion (Evans et al., 2005). 
Using specific pharmacological inhibitors, like cox-2 inhibitor NS-398 which was much more 
effective than the COX-1 inhibitorSC560, basal Isc may be moderately inhibited byCOX-2-
mediated prostaglandin synthesis and that COX-2 mediated a large fraction of endothelin-
 
 
induced inhibition of Isc (Evans et al., 2005).. COX-1 and COX-2 cDNAs have been cloned 
from rainbow trout (Onchorynchus mykiss) (Zou et al., 1999), brook trout (Salvelinus 
fontinalis) (Roberts et al., 2000) and zebrafish (Danio rerio) (Grosser et al., 2002), and genome 
sequences predict the presence of both isoforms in puffer fish (Fugu rubripes), demonstrating 
that teleosts have both isoforms (Jarving et al., 2004). constitutive branchial COX-2 expression 
is also enhanced in seawater, where prostaglandins can regulate NaCl secretion in chloride 
cells in gills of the euryhaline killifish (Fundulus heteroclitus)(Choe et al., 2006).Since is 
selective cox-2 inhibitor more pronounced effect is expected to be seen on osmoregulation  in 
tilapia,but, for  most  studies,  fish from  domesticated  stocks  have  been  used,  and  such  fish 
may  have  a  blunted  stress  response  when  compared  with wild-type  strains  of  the  same  
species  (Woodward & Strange., 1987). Tilapia also can maintain internal osmotic balance 
without any change in drinking rate or branchial Na+, K+-ATPase activity when exposed to 
salinities up to 65 g/l for five days.  At 65 g/l salinity or greater, there are changes in chloride 
cell turnover, drinking rate, and Na+, K+-ATPase activity; followed by increases in plasma 
osmolality and ion levels (Sardella et al., 2004).   
The feces sample injected to HPLC system, showed no peak for Etoricoxib (see appendix). As 
a result all Etoricoxib is metabolized and the metabolites are excreted with no unchanged 
fraction of the drug. This is in contrast to humans,where minor fraction of the dose (<1%) is 
excreted unchanged (Rodrigues et al., 2003).In healthy male subjects, Etoricoxib is well 
absorbed, with an absolute oral bioavailability of 83%. and a low clearance with a t1/2 of 
24.8h. In addition, Etoricoxib is metabolized extensively (more than 98%) via6-methyl 
hydroxylation (major) and1-N-oxidation. These metabolites are either excreted directly, or are 
metabolized further to secondary metabolites that are also excreted largely by urine(70%) and 
20% by feces with less than 2% recovered unchanged as(Etoricoxib). 6-Carboxylic acid 
derivative of Etoricoxib  is the major metabolite observed the oxidative metabolism is 
catalyzed by multiple P450s in the presence of NADPH-fortified human liver microsomes, 
with CYP3A4 playing an Important role (60%), and the remainder of the activity shared more 
or less equally among other P450s (e.g., CYP2C9, 2D6, 1A2, and 2C19) (Kassahun et al., 
2001).Because of the low levels in plasma and weak COX-2 activity, the metabolites of 
Etoricoxib are unlikely to contribute to the inhibition of COX-2 in vivo (Rodrigues et al., 
2003). Moreover, the involvement of multipleP450s, and the low first pass effect, as the 
hepatic extraction is calculated to be 0.04, with negligible gut first pass metabolism, effectively 
minimizes the potential for significant drug interactions with potent P450 inhibitors (Rodrigues 
 
 
et al., 2003). We do not know if it’s, low first pass effect, with high bioavailability and low 
hepatic extraction ratio, contributes to its long t1/2=28.6h, renders it available to systemic 
circulation and increase its toxicity towards fish. Unrecovered of unchanged drug from feces as 
shown in appendix, could indicate that etoricoxib was either extensively metabolized by liver 
or some of the drug have undergone enterohepatic circulation. While renal excretion is the 
most important route for final elimination of NSAIDs, nearly all undergo varying degrees of 
biliary excretion and reabsorption (enterohepatic circulation). In fact, the degree of lower 
gastrointestinal tract irritation correlates with the amount of enterohepatic circulation. Far, 
there is no report on etoricoxib and enterohepatic circulation (Brune et al., 2010). However, 
enterohepatic recirculation is unique to rofecoxib and has been reported in both rat and human 
studies, with resultant biphasic serum peaks of drug (Huntjens et al., 2008). On the other 
hand,Diclofenac undergo enterohepatic recirculation in brown trout  and tend to form protein 
adducts which are responsible for kidney  and liver pathology (Schwaiger et 
al.,2004).Prolonged availability of Diclofenac in the brown trout due to enterohepatic cycling 
promotes its accumulation, despite its basically low tendency for bioaccumulation as judged by 
its octanol/water partition coefficient.(Hoeger et al., 2008).The uptake and metabolism of anti-
inflammatory drug diclofenac (DCF) was studied by exposing rainbow trout (Oncorhynchus 
mykiss) to DCF intraperitoneally, and via water at concentration of 1.7 µg L−1. Unmetabolized 
DCF was detected in the bile with bioconcentration factors (BCFtotal-bile for DCF and its 
metabolites) which, varied between individuals ranging from 320 to 950(Kallio et al., 2010). 
This finding suggest that fish living downstream the wastewater treatment plants (WWTPs) 
and which are chronically exposed to the drug may accumulate the drug and its metabolites in 
bile.Although most of these pharmaceuticals undergo extensive dilution and degradation 
during sewage treatment, the potential effects of COX inhibitors on physiologic functions in 
fish will require attention, particularly as human longevity increases requiring greater use of 
anti-inflammatory drugs. Thus it should be investigated further for their ability to alter fish 
thyroidal status, and reproduction chronically. 
 
 
Chapter Six 
 
 6.1 Conclusions   
Based upon my work and the experiments done, The effect of COXs-2 inhibitors treatment 
on NileTilapia is maximally exerted during a critical period of sex differentiation, which 
occurs in tilapia fry between 2 and 6 weeks after spawning. After   the end of this period 
there was no effect on the growth rate. Thus, COX-2 inhibitors could   modulate aromatase 
activity needed for proper sexual development and reproduction during the crucial period. 
The highest growth rate was with (2% Etodolac) followed by (1% Etodolac), but optimum 
dose with lower mortality(3.4% and10%) was with (0.5%Etodolac),and (0.5%Etoricoxib) 
which show SGR(%) of 4.93 and 4.64 respectively.(1% Etoricoxib) showed  a decreased 
growth rate compared to standard which could indicates a toxic potential of Etoricoxib 
toward fish at this concentration. (0.5%Etodolac),and (0.5%Etoricoxib) could be the 
optimum dose for improving growth rate with lower mortality. Etoricoxib  have been 
metabolized in the fish body   with no change in the movement, appetite for food or any 
other differences in compared with the fish treated with both  drugs compared  to control 
during  the experimental period.Since Etodolac is non-selective COX-1 inhibitor with 
preferential COX-2 selectivity and Etoricoxib is selective COX-2 inhibitor,COX- 2 may 
be constantly expressed  as COX-1 in fish,as in contrast to mammalian red blood cells,the 
nucleated erythrocytes of fishes posses a significant ability to synthesize 
prostaglandins,resulting in its availability in any well perfused  organ. This study   further 
highlights the potential endocrine-disrupting impact of environmental chemicals, which 
interfere with steroidogenesis and the P450arom system. Furthermore, this is the first time 
to our knowledge we test the effects of these agents on fry teleosts during the crucial 
period of sexual development which points to possible alterations in reproduction 
following chronic exposure to these drugs at an early stage in contaminated surface water. 
Subsequent field investigations in normal aquaculture bonds are needed to confirm these 
results in larger population, using different classes of COXs-inhibitors at different 
concentrations. 
 
 
 
 
 
 
6.2 Recommendations:  
• First of all the work in any part of aquaculture experiment need a lot of patience, 
accuracy, sincerely and commitment during every step in the experiments because 
you were dealing with living organisms. 
• To achieve super-fast growth rate, and to get a marketable fish size the 
environment should be ideal for particular strain, water quality, salinity, climate 
and stock density.  
• Further detail research in histopathology about the effect of NSAIDs on the 
internal organs should be done to know more about the effect of Etodolac and 
Etoricoxib drugs on cells physiology. 
• The wastewater which was used during the experiment should be used for other 
efficient activities such as agricultural; the wastewater from fish aquaculture was 
very works as a fertilizer if we use suitable crops that tolerate the component of 
this type of water . 
• Further studies should be done on the same subject by increasing the feeding 
allowance daily three times of both drugs.in two side by increase the dose to know 
the LC50, and decrease the dose to know the EC50 . 
• Other studies should be done by mixing many type of pharmaceutical together 
because the pollution inside aquatic environment contain mixed of different 
pharmaceutical product not only one type. 
• ALQuds University wastewater treatment plant should provide other techniques 
and more interested about the method used to remove NSAIDs from wastewater. 
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Appendix  
Experiment number (4): Niletilapia feces analysis for etoricoxib  
4 months age niletilapia were separated in one aquarium from the recirculating system and 
given diet with 1% etoricoxib and after half an hour collect its feces, and collect a second 
sample after 1 hour then after 2hour, after 3 hour, after 4 houres ,24 houres each sample 
with triplicate and then the analysis done by using HPLC device in the analysis center lab 
in ALQuds University. 
Determination of Etoricoxib in fish feces by HPLC: 
A simple reverse phase HPLC method has developed for estimation of Etoricoxib in fish 
feces.the method was carried out on a Water X bridge 5 Mm, C8 column with a mobile 
phase consisting of methanol:  Acetonitrile: phosphate  buffer 3.5(40: 20: 40 V\ V) at flow 
rate of 1ml/min, detection was carried out at 210nm and the retention time of Etoricoxib 
was 4.18 min. 
Calibration Curve:  
Linearity of a system was investigated by serially diluting the stock solution to give 
concentration in the range 20-100 mg/ 1000ml(ppm). an aliquot (10 ml) was injected using 
a mixture methanol: acetonitrile: phosphate buffer pH 3.5 (40:20:40) V/V as mobile 
phase.Calibration curve were obtained by plotting the peak area versus concentration the 
calibration curve is as shown  
 
 
 
Treatment & preparation of feces sample to determined the presence of Etoricoxib  
Four sample of fish feces taken in each 2  hours after feeding of the fish, each sample 
obtained by three –collection, and then each sample that is come from collection  of three 
time homogenate  and mixed at room temperature then 5ml were transferred to glass 
centrifuge tube &then 15ml added from phosphoric acid to acidify the sample to 
approximately PH=3 &then 10ml of acetonitrile ⁄ methanol (2:1) and after centrifuge the 
supernate were transferred to clean tube.and the sample transferred to vial and injected. 
HPLC RESULTS  
HPLC Peaks for the feces injected sample in Nile Tilapia Results show that : there was no 
any peak for Etoricoxib in the sample injected to HPLC system.  
so as a result all etoricoxib is metabolized with no unchanged fraction excreted.  
 
                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   ﺍﻟﻤﻠﺨﺹ
ﻜﺜﻴﺭ ﻤﻥ ﺍﻟﺩﺭﺍﺴـﺎﺕ ﺃﺠﺭﻴـﺕ ﻟﻠﺘﻨﺒـﺅ ﺒﺎﻟﺘـﺄﺜﻴﺭ ﺍﻟﻤﺒﺎﺸـﺭ ﻋﻠـﻰ ﺘﺜﺒـﻴﻁ ﻋﻤـل ﻭﻨﺸـﺎﻁ ﺇﻨـﺯﻴﻡ 
ﻭﻫﻭ ﺍﻹﻨﺯﻴﻡ ﺍﻟﻤﺤﺩﺩ ﻟﻤﻌﺩل ﺘﻐﻴﻴﺭ ﻫﺭﻤﻭﻥ ﺍﻷﻨﺩﺭﻭﺠﻴﻥ ﻭﺘﺤﻭﻴﻠـﻪ  emyzne esatamoraﺍﻷﺭﻭﻤﺎﺘﻴﺯ
ﺃﻗل ﻀـﺭﺭﺍﹰ ﻭﻜﻭﻨﻬﺎ .  ﺃﺴﺘﺭﻭﺠﻴﻥ ﻭﻫﻭ ﺍﻟﻬﺭﻤﻭﻥ ﺍﻟﻀﺭﻭﺭﻱ ﻟﺘﻤﺎﻴﺯ ﺨﻼﻴﺎ ﺍﻟﻤﺒﻴﺽ ﻓﻲ ﺍﻷﺴﻤﺎﻙ ﺇﻟﻰ 
ﻋﻠﻰ ﺍﻟﺒﻴﺌﺔ ﻤﻘﺎﺭﻨﺔ ﺒﻤﺎﺩﺓ ﺍﻟﻤﻴﺜﻴل ﺘﺴﺘﻭﺴﺘﻴﺭﻭﻥ ﺍﻟﺘﻲ ﺘﺴﺘﺨﺩﻡ ﺤﺎﻟﻴﺎﹰ  ﻟﺘﻐﻴﻴﺭ ﺠﻨﺱ ﺍﻷﺴﻤﺎﻙ ﻭﻫﻲ ﻤـﺎﺩﺓ 
ﻫﻲ ﺃﺩﻭﻴﺔ ﻓﻌﺎﻟﺔ ﻭﻏﻴـﺭ ﻤﻨﻌﻜﺴـﺔ ﺒﺎﺘﺠـﺎﻩ 2-XOCﻤﺜﺒﻁﺎﺕ ﺍﻹﻨﺯﻴﻡ ﺍﻹﺨﺘﻴﺎﺭﻴﺔ ل. ﻀﺎﺭﺓ ﺠﺩﺃﺒﺎﻟﺒﻴﺌﺔ
  .yawhtaP2-XOC
ﺕ ﻨﺘﺎﺌﺠﻬـﺎ ﺃﻥ ﺍﺴـﺘﺨﺩﺍﻡ ﻫـﺫﻩ ﻜﺜﻴﺭ ﻤﻥ ﺍﻟﺩﺭﺍﺴﺎﺕ ﺍﻟﺘﻲ ﺃﺠﺭﻴﺕ ﻋﻠﻰ ﺨﻼﻴﺎ ﺍﻟﺜﺩﻱ ﺍﻟﺴﺭﻁﺎﻨﻴﺔ ﺃﻅﻬﺭ
ﺍﻷﺩﻭﻴﺔﻋﻠﻰ ﺍﻟﺨﻼﻴﺎ ﺍﻟﺴﺭﻁﺎﻨﻴﺔ ﻴﺅﺩﻱ ﺍﻟﻰ ﺘﻘﻠﻴل ﻤﻌﺩل ﺍﻟﻨﺴﺦ ﻟﻠﺤﻤﺽ ﺍﻟﻨـﻭﻭﻱ ﺍﻟﺭﺍﻴﺒـﻭﺯﻱ ﺍﻟﻨﺎﻗـل 
  .ﻟﻬﺫﺍ ﺍﻹﻨﺯﻴﻡ  ANRm
ﻓﻲ ﺘﺠﺭﺒﺘﻨﺎ ﻫﺫﻩ ﺍﻟﺘﻲ ﺃﺠﺭﻴﺕ، ﺍﺨﺘﺒﺭﻨﺎ ﺘﺄﺜﻴﺭ ﺘﺯﻭﻴﺩ ﺼﻐﺎﺭ ﺍﻷﺴﻤﺎﻙ ﺒﻐﺫﺍﺀ ﻴﺤﺘﻭﻱ ﻋﻠﻰ ﻫﺫﻩ ﺍﻷﺩﻭﻴـﺔ 
ﺨـﻼل  ( bixocirotEﻭ  calodotE) ﻲ ﻤـﺎﺩﺘﻲ ﻭﻫ  ـ 2-XOCﺍﻻﺨﺘﻴﺎﺭﻴﺔ ﺍﻟﻤﺜﺒﻁﺔ ﻟﻌﻤل ﺇﻨﺯﻴﻡ 
ﻤﻥ ﻨﺎﺤﻴﺔ ﺃﺨﺭﻯ ﻴـﺯﺩﺍﺩ . ﺍﻟﻤﺭﺤﻠﺔ ﺍﻷﻭﻟﻰ ﻤﻥ ﺤﻴﺎﺓ ﺍﻷﺴﻤﺎﻙ ﻟﻨﺩﺭﺱ ﺘﺄﺜﻴﺭﻫﺎ ﻋﻠﻰ ﻤﻌﺩل ﺍﻟﻨﻤﻭ ﻭﺍﻟﻭﻓﺎﺓ
ﺍﻟﻜﺸﻑ ﻋﻥ ﻫﺫﻩ ﺍﻷﺩﻭﻴﺔ ﺍﻟﺒﺸﺭﻴﺔ ﻭﺍﻟﺤﻴﻭﺍﻨﻴﺔ ﺒﻜﻤﻴﺎﺕ ﻜﺒﻴﺭﺓ ﻓﻲ ﺍﻟﻤﻴﺎﻩ ﺍﻟﺼﺎﺩﺭﺓ ﻤﻥ ﻤﺤﻁﺎﺕ ﺍﻟﻤﻌﺎﻟﺠﺔ 
ﺭ ﺍﻟﺴﺘﻴﺭﻭﻴﺩﻴﺔ ﺍﻟﻤﻀﺎﺩﺓ ﻟﻺﻟﺘﻬﺎﺏ  ﻭﺍﺤـﺩﺓ ﻤـﻥ ﻤﻌﻅـﻡ ﻭﺍﻟﻤﻴﺎﻩ ﺍﻟﺴﻁﺤﻴﺔ ﻭﺒﺎﻟﺫﺍﺕ ﺘﺸﻜل ﺍﻷﺩﻭﻴﺔ ﻏﻴ
  .ﺍﻷﺩﻭﻴﺔ ﻭﺍﻟﻤﺭﻜﺒﺎﺕ ﺍﻟﺸﺎﺌﻌﺔ ﺍﻟﺘﻲ ﺘﻭﺠﺩ ﻓﻲ ﺍﻟﻤﻴﺎﻩ 
ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﺘﻲ ﺘﻬﺘﻡ ﺒﺨﻁﺭ ﻫﺫﻩ ﺍﻷﺩﻭﻴﺔ ﻭﺴﻤﻴﺘﻬﺎ ﻋﻠﻰ ﺍﻟﺒﻴﺌﺔ ﻨﺎﺩﺭﺓ ﻭﻗﻠﻴﻠﺔ ﺠﺩﺍﹰ، ﻭﻻ ﺘﻭﺠﺩ ﻤﻌﻠﻭﻤـﺎﺕ 
  .ﻤﺘﻭﻓﺭﺓ ﻋﻥ ﺘﺄﺜﻴﺭ ﻫﺫﻩ ﺍﻷﺩﻭﻴﺔ ﻋﻠﻰ ﺍﻷﺴﻤﺎﻙ ﺒﻌﺩ ﻓﺘﺭﺓ ﻁﻭﻴﻠﺔ ﻤﻥ ﺍﻟﺘﻌﺭﺽ ﻟﻬﺎ
ﻓﻲ  bixocirotEﺍﻟﺩﻭﺍﺌﻴﺔ  ﺘﻡ ﻋﻥ ﻁﺭﻴﻕ ﺘﺤﺩﻴﺩ ﻭﺠﻭﺩ ﻤﺎﺩﺓ( bixocirotE)ﺘﺴﻠﻴﻁ ﺍﻟﻀﻭﺀ ﻋﻠﻰ ﻤﺎﺩﺓ 
  . CLPHﻓﻀﻼﺕ ﺍﻷﺴﻤﺎﻙ ﻋﻥ ﻁﺭﻴﻕ ﺍﻟﺘﺤﻠﻴل ﺒﻭﺍﺴﻁﺔ ﺠﻬﺎﺯ 
ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻓﻲ ﻤﺨﺘﺒﺭ ﺍﻟﺯﺭﺍﻋﺔ ﺍﻟﺴﻤﻜﻴﺔ ﻟﻸﺒﺤﺎﺙ ﻓﻲ ﺠﺎﻤﻌﺔ ﺍﻟﻘﺩﺱ، ﺤﻴﺙ ﻗﻤـﺕ ﺒﺘﻭﺯﻴـﻊ 
ﻠﻰ ﺍﻷﺤﻭﺍﺽ ﺍﻟﺘﻲ ﺘﻡ ﺘﺠﻬﻴﺯﻫﺎ ﻤﺴﺒﻘﺎﹰ ﻻﺤﺘﻀﺎﻥ ﻫﺫﻩ ﻋ(ﺃﻴﺎﻡ ﺒﻌﺩ ﺍﻟﻔﻘﺱ 8ﻋﻤﺭﻫﺎ )ﺍﻷﺴﻤﺎﻙ ﺍﻟﺼﻐﻴﺭﺓ 
  .ﺍﻷﺴﻤﺎﻙ
ﻓﻲ ﻜل ﺤـﻭﺽ ( sucitolin.simorhcoero)ﻤﻥ ﻨﻭﻉ (  ﺫﻜﻭﺭ ﻭﺇﻨﺎﺙ)ﺴﻤﻜﺔ ﺨﻠﻴﻁ  03ﺘﻡ ﻭﻀﻊ 
ﺍﻟﻤﻌﺎﻟﺠـﺔ ( . metsyS gnitalucriceR)ﻟﺘﺭﺍﹰ ﻤﻥ ﺍﻟﻤﺎﺀ ﻓﻲ ﻨﻅﺎﻡ ﻤﻐﻠﻕ 54ﺍﻟﺫﻱ ﺘﺒﻠﻎ ﺴﻌﺘﻪ ﺘﻘﺭﻴﺒﺎﹰ 
+ bixocirotEﻤـﻥ ﻤـﺎﺩﺓ  %5.0ﻭﻫﻲ ﻜﻤﺎ ﻴﻠﻲ ﺘﺭﻜﻴﺯ .ﺘﻤﺕ ﺒﺎﺴﺘﺨﺩﺍﻡ  ﺘﺭﺍﻜﻴﺯ ﻤﺨﺘﻠﻔﺔ ﻤﻊ ﺍﻟﻐﺫﺍﺀ 
 
 
ﻤـﻥ ﻤـﺎﺩﺓ %1ﺍﻟﻐـﺫﺍﺀ، + bixocirotEﻤﻥ ﻤـﺎﺩﺓ % 1ﺍﻟﻐﺫﺍﺀ، + calodotEﻤﻥ  %5.0ﺍﻟﻐﺫﺍﺀ،
ﺍﻟﻐﺫﺍﺀ  ﻜل ﻭﺍﺤﺩﺓ ﻤﻥ ﻫﺫﻩ ﺍﻟﺘﺭﺍﻜﻴﺯ ﻴﺘﻡ ﺘﻁﺒﻴﻘﻬﺎ ﻓﻲ ﺤﻭﻀﻴﻥ +calodotE% 2ﺍﻟﻐﺫﺍﺀ،+ calodotE
ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺤﻭﻀﻴﻥ ﺇﻀﺎﻓﻴﻴﻥ ﻴﺘﻡ ﺇﻋﻁﺎﺀ ﺍﻷﺴﻤﺎﻙ ﻏﺫﺍﺀ ﻋﺎﺩﻱ ﺒﺩﻭﻥ ﻭﺠﻭﺩ ﺃﺩﻭﻴـﺔ ﺤﺘـﻰ ﺘﻜـﻭﻥ 
ﻏـﻡ  021ﻤﻊ   calodotEﻤﻐﻡ ﻤﻥ 006ﺘﻡ ﺘﺤﻀﻴﺭ ﻫﺫﻩ ﺍﻟﺘﺭﺍﻜﻴﺯ ﻋﻥ ﻁﺭﻴﻕ ﺨﻠﻁ . ﻤﺭﺠﻊ ﻟﻠﺘﺠﺭﺒﺔ 
ﻋﻠـﻰ % 2، %1،  5.0%ﺴﻤﺎﻙ ﻟﺘﺤﻘﻴﻕ ﺍﻟﺘﺭﺍﻜﻴﺯ ﻏﻡ ﻤﻥ ﻏﺫﺍﺀ ﺍﻷ03ﻏﻡ ، 06ﻤﻥ ﺍﻟﻐﺫﺍﺀ ﺍﻟﻌﺎﺩﻱ ، 
ﻤﻊ  bixocirotEﻤﻐﻡ ل 09ﻋﻥ ﻁﺭﻴﻕ ﺨﻠﻁ bixocirotEﻭﺍﻟﻌﻤﻠﻴﺔ ﻨﻔﺴﻬﺎ ﺘﻡ ﻋﻤﻠﻬﺎ  ﻟﻤﺎﺩﺓ . ﺍﻟﺘﻭﺍﻟﻲ 
  .ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻲ % 1، % 5.0ﻏﻡ  ﻤﻥ ﻏﺫﺍﺀ ﺍﻷﺴﻤﺎﻙ ﻟﺘﺤﻘﻴﻕ ﺘﺭﺍﻜﻴﺯ 9ﻏﻡ ، 81
ﺸﻬﺭﻴﻥ ﻓﻲ ﻨﻅﺎﻡ  ﻓﻲ ﻋﻤﺭ ﺃﻜﺜﺭ ﻤﻥ( ﺫﻜﻭﺭ ﻭﺇﻨﺎﺙ )ﺃﺴﻤﺎﻙ ﺨﻠﻴﻁ  01ﺘﻡ ﻭﻀﻊ  -:ﻓﻲ ﺘﺠﺭﺒﺔ ﺃﺨﺭﻯ 
 % 5.0ﻤﻐﻠﻕ ﻭﻜل ﻨﻭﻉ ﻴﺘﻡ ﺘﻁﺒﻴﻘﻪ ﻓﻲ ﺜﻼﺜﺔ ﺃﺤﻭﺍﺽ ﻭﺘﻡ ﻤﻌﺎﻤﻠﺘﻬﺎ ﻜﻤﺎ ﻓﻲ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺴﺎﺒﻘﺔ ﻟﺘﺭﻜﻴﺯ 
 .calodotE%  5.0ﻭbixocirotE
ﺍﻟﺘﻐﺫﻴﺔ ﻭﺍﻟﻤﻌﺎﻟﺠﺔ ﺒﺩﺃﺕ ﻓﻲ ﻨﻔﺱ ﺍﻟﻴﻭﻡ ﺍﻟﺫﻱ ﻭﻀﻌﺕ ﻓﻴﻪ ﺍﻷﺴﻤﺎﻙ ﻓﻲ ﻫﺫﺍ ﺍﻟﻨﻅـﺎﻡ ، ﻭﻴـﺘﻡ ﺇﻁﻌـﺎﻡ 
ﻤﻥ ﻭﺯﻥ ﺍﻟﺴﻤﻙ ﺍﻟﻜﻠﻲ ﻓﻲ ﻜل % 01ﺍﻟﺘﻲ ﻜﺎﻨﺕ ﺘﻌﻁﻰ ﺘﻤﺜل ﻜﻤﻴﺔ ﺍﻟﻐﺫﺍﺀ .ﺍﻷﺴﻤﺎﻙ ﻤﺭﺓ ﻭﺍﺤﺩﺓ ﻴﻭﻤﻴﺎﹰ 
ﺨﻼل ﻓﺘﺭﺓ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻭﻋﻨﺩﻤﺎ ﻴﺘﻡ ﺇﻴﻘﺎﻑ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺒﺎﻷﺩﻭﻴﺔ، ﻴﺼـﺒﺢ ﻭﺯﻥ ﺍﻟﻐـﺫﺍﺀ ﺍﻟﻤﻌﻁـﻰ .ﺤﻭﺽ 
  .ﻤﻥ ﻭﺯﻥ ﺍﻟﺴﻤﻙ ﺍﻟﻜﻠﻲ ﻓﻲ ﺍﻟﺤﻭﺽ %5
ﺘﻡ ﺘﻭﺯﻴﻥ ﺍﻷﺴﻤﺎﻙ ﻓﻲ ﻜل ﺃﺴﺒﻭﻉ ﻭﺘﻡ ﻋﺩ ﺍﻷﺴﻤﺎﻙ ﻓﻲ ﻜـل ﺤـﻭﺽ ﻟﻤﻌﺭﻓـﺔ ﻭﺤﺴـﺎﺏ ﻤﻌـﺩل 
ﻏﻡ ﺒﺎﺴﺘﺨﺩﺍﻡ 1.0ﺘﻡ ﺘﻭﺯﻴﻥ ﺍﻷﺴﻤﺎﻙ ﻓﻲ ﻜل ﺤﻭﺽ ﻷﻗﺭﺏ.ﺃﺴﺎﺒﻴﻊ ﺍﻟﺘﺠﺭﺒﺔ ﺨﻼل   etar lavivruS
  .  elacs latigidﺍل 
   tXb+a=tYﻤﻌﺩل ﺍﻟﻨﻤﻭ ﺘﻡ ﺤﺴﺎﺒﻪ ﻋﻥ ﻁﺭﻴﻕ ﻤﻌﺎﺩﻟﺔ ﻤﻴل ﺍﻟﺨﻁ ﺍﻟﻤﺴﺘﻘﻴﻡ 
  ﺘﻤﺜل ﻤﻌﺩل ﺍﻟﻭﺯﻥ ﺍﻟﻜﻠﻲ  :tY
  ﺘﻤﺜل  ﺍﻟﻭﻗﺕ :t
  . ﺘﻤﺜل ﻤﻌﺩل ﺍﻟﻭﺯﻥ ﻟﻸﺴﻤﺎﻙ ﻋﻨﺩ ﺒﺩﺀ ﺍﻟﺘﺠﺭﺒﺔ  :a
ﺍﻟﻭﺯﻥ ﺍﻟﻨﻬﺎﺌﻲ ﻟﻠﺠﺴﻡ ، ﺍﻟﻭﺯﻥ ﺍﻟﻤﻜﺘﺴـﺏ ،ﻭﻤﻌـﺩل ) ﻼﻑ ﻓﻲ ﻤﻌﺩل ﺍﻟﻨﻤﻭ ﺃﻅﻬﺭﺕ ﺍﻟﻨﺘﺎﺌﺞ ﺃﻥ ﺍﻻﺨﺘ
 2-XOCﺘﻡ ﺘﻐﺫﻴﺘﻪ ﺒﻐﺫﺍﺀ ﻤﺨﻠﻭﻁ ﻤﻊ ﺍﻷﺩﻭﻴﺔ ﺍﻟﻤﺜﺒﻁﺔ ﻟﻌﻤـل ﺇﻨـﺯﻴﻡ    sucitolin.oﻟﺴﻤﻙ ( ﺍﻟﻨﻤﻭ
ﻜﺎﻥ ﺃﻋﻠﻰ ﻤﻌﺩل ﻟﻠﻨﻤﻭ ﺤﺴﺏ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺘﻲ ﺃﺠﺭﻴﺕ ﻓﻲ ﺘﺭﻜﻴـﺯ ( .bixocirotE،calodotE)ﻟﻤﺎﺩﺘﻲ 
ﻴﻠﻴﻪ ﺍﻷﺴﻤﺎﻙ ﻓﻲ ﺍﻷﺤﻭﺍﺽ ﺍﻟﻌﺎﺩﻴﺔ ﺍﻟﺘﻲ ﺘﺘﻐﺫﻯ  bixocirotE% 5.0ﻴﻠﻴﻪ ﺘﺭﻜﻴﺯ  calodotE%5.0
ﺃﻴـﺎﻡ  8ﻫﺫﻩ ﺍﻟﻨﺘﺎﺌﺞ ﺘﺘﻌﻠﻕ ﺒﺎﻟﺘﺠﺭﺒﺔ ﺍﻟﺘﻲ ﺒﺩﺃﻨﺎ ﺒﺈﻋﻁﺎﺀ ﺍﻷﺩﻭﻴﺔ ﻤﻊ ﺍﻟﻐﺫﺍﺀ ﻤـﻥ ﻋﻤـﺭ . ﺒﻐﺫﺍﺀ ﻋﺎﺩﻱ 
 
 
ﺃﻤﺎ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺜﺎﻨﻴﺔ ﺍﻟﺘﻲ ﻜﺎﻥ ﻋﻤﺭ ﺍﻷﺴﻤﺎﻙ ﻓﻴﻬﺎ ﺃﻜﺜﺭ ﻤﻥ ﺸﻬﺭﻴﻥ ﻓﻠﻡ ﺘﻅﻬـﺭ ﺍﻟﻨﺘـﺎﺌﺞ ﺃﻱ . ﻟﻸﺴﻤﺎﻙ
  .ل ﺍﻟﻨﻤﻭﺯﻴﺎﺩﺓ ﺃﻭ ﻨﻘﺼﺎﻥ ﻓﻲ ﻤﻌﺩ
ﻴﻠﻴﻬـﺎ  calodotE% 2ﻤﻌﺩل ﺍﻟﺯﻴﺎﺩﺓ ﻓﻲ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻷﻭﻟﻰ ﻜـﺎﻥ ﺃﻋﻠـﻰ ﻤـﺎ ﻴﻤﻜـﻥ ﻓـﻲ ﺘﺭﻜﻴـﺯ 
ﺃﻅﻬﺭ ﻨﻘﺼﺎﻥ ﻓﻲ ﻤﻌﺩل ﺍﻟﻨﻤﻭ ﺒﺎﻟﻤﻘﺎﺭﻨـﺔ bixocirotE % 1ﻭﻟﻜﻥ ﺍﻟﺤﻭﺽ ﺒﺘﺭﻜﻴﺯ   calodotE%1
ﻤﻊ ﺍﻷﺤﻭﺍﺽ ﺍﻟﻌﺎﺩﻴﺔ ﻭﺍﻟﺘﻲ ﻴﻤﻜﻥ ﺃﻥ ﺘﻅﻬﺭ ﺃﻥ ﻫﺫﺍ ﺍﻟﺘﺭﻜﻴﺯ ﻤﻤﻜﻥ ﺃﻥ ﻴﻜﻭﻥ ﺴﺎﻡ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻸﺴـﻤﺎﻙ 
ﻓﻲ ﻓﻀﻼﺕ ﺍﻷﺴـﻤﺎﻙ ﺍﻟﺘـﻲ ﺘـﻡ   bixocirotEﻓﺔ ﺇﻟﻰ ﺫﻟﻙ ﻟﻡ ﻴﺘﻡ ﺍﻟﻜﺸﻑ ﻋﻥ ﻭﺠﻭﺩ ﻤﺎﺩﺓ ﺒﺎﻹﻀﺎ.
ﺃﺸـﻬﺭ  4ﺴﺎﻋﺔ ﻤﻥ ﺴﻤﻜﺔ ﻋﻤﺭﻫـﺎ  42ﺴﺎﻋﺎﺕ ﻭﺒﻌﺩ 4ﺴﺎﻋﺎﺕ  ، 3ﺃﺨﺫﻫﺎ ﺒﻌﺩ ﻨﺼﻑ ﺴﺎﻋﺔ ،ﺴﺎﻋﺔ ،
ﺘـﻡ   bixocirotEﻤـﺎﺩﺓ   ، ﻭﻫﺫﻩ ﺍﻟﻨﺘـﺎﺌﺞ ﺘﻅﻬـﺭ ﺃﻥ CLPHﻭﺘﺤﻠﻴل ﻫﺫﻩ ﺍﻟﻌﻴﻨﺎﺕ ﺒﻭﺍﺴﻁﺔ ﺠﻬﺎﺯ 
ﻟﻡ ﻴﺘﻡ ﺍﻟﻜﺸـﻑ   bixocirotEﺇﻤﺘﺼﺎﺼﻬﺎ ﻤﻥ ﻗﺒل ﺍﻷﺴﻤﺎﻙ ﻭﻟﻡ ﻴﺘﻡ ﺍﻟﻌﺜﻭﺭ ﻋﻠﻰ ﺃﻱ ﺠﺯﺀ ﻤﻥ ﻤﺎﺩﺓ 
ﻋﻥ ﻭﺠﻭﺩﻩ ﻤﻤﺎ ﻴﻌﻨﻲ ﺃﻥ ﺍﻟﺠﺴﻡ ﻗﺩ ﻗﺎﻡ ﺒﺎﻤﺘﺼﺎﺼﻪ ﻭﺘﺤﻭﻴﻠﻪ ﺇﻟﻰ ﻤﺭﻜﺒﺎﺕ ﺃﺨﺭﻯ ﺩﺍﺨل ﺍﻟﺠﺴﻡ ﻭﻤـﻥ 
ﺓ ﻟـﻡ ﺍﻟﻤﻤﻜﻥ ﺃﻨﻪ ﺩﺨل ﺍﻟﺩﻭﺭﺓ ﺍﻟﺩﻤﻭﻴﺔ ﻟﻠﻜﺒﺩ ﻭﻫﺫﺍ ﻴﺅﺩﻱ ﺇﻟﻰ ﺯﻴﺎﺩﺓ ﺴﻤﻴﺘﻪ ﻟﻠﺠﺴﻡ ﻭ ﻓﻲ ﺍﻷﺴﻤﺎﻙ ﺍﻟﻜﺒﻴﺭ
ﻴﻜﻥ ﻫﻨﺎﻙ ﺃﻱ ﺤﺎﻟﺔ ﻭﻓﺎﺓ ﺨﻼل ﻓﺘﺭﺓ ﺍﻟﺘﺠﺭﺒﺔ ، ﺃﻤﺎ ﻓﻲ ﺍﻷﺴﻤﺎﻙ ﺍﻟﺼﻐﻴﺭﺓ ﻟﻡ ﻴﻜﻥ ﻫﻨﺎﻙ ﺍﺨﺘﻼﻑ ﻓـﻲ 
ﻭﻟﻜﻥ ﻤﻌﺩل ﺍﻟﺒﻘﺎﺀ ﻋﻠﻰ ﻗﻴﺩ ﺍﻟﺤﻴـﺎﺓ ﻜـﺎﻥ  bixocirotE%5.0ﻭ calodotE%5.0ﻤﻌﺩل ﺍﻟﻭﻓﺎﺓ ﺒﻴﻥ 
ﺍﻟﺘـﻲ ﻜﺎﻨـﺕ ﻨﺴـﺒﺘﻬﺎ ( ﺩﻭﻥ ﻤﻌﺎﻟﺠﺔ)ﻭﻫﻭ ﺃﺤﺴﻥ ﺒﺎﻟﻤﻘﺎﺭﻨﺔ ﻤﻊ ﺍﻷﺤﻭﺍﺽ ﺍﻟﻌﺎﺩﻴﺔ % 09ﻭ% 6.69
 bixocirotE%1ﻤﻌﺩل ﻭﻓﺎﺓ ﻋﺎﻟﻲ ﻅﻬﺭ ﻤﻊ ﺯﻴﺎﺩﺓ ﺍﻟﺘﺭﺍﻜﻴﺯ .ﺨﻼل ﻓﺘﺭﺓ ﺍﻟﺘﺠﺭﺒﺔ % 3.38-%6.68
   . calodotE%2ﻭ calodotE% 1ﻭ 
ﻓﻲ ﻏـﺫﺍﺀ ﺍﻷﺴـﻤﺎﻙ ﻤﻔﻴـﺩﺓ ﻟﻨﻤـﻭ   2-XOCﻫﺫﻩ ﺍﻟﻨﺘﺎﺌﺞ ﺘﻅﻬﺭ ﺃﻥ ﺇﻀﺎﻓﺔ ﺍﻷﺩﻭﻴﺔ ﺍﻟﻤﺜﺒﻁﺔ ﻹﻨﺯﻴﻡ 
ﺍﻟﺠﻨﺴﻲ ﻟﻸﺴﻤﺎﻙ ﻭﻫـﺫﻩ  ﺍﻷﺴﻤﺎﻙ ﻭﻫﺫﺍ ﺍﻟﺘﺄﺜﻴﺭ ﻴﻅﻬﺭ ﻭﺍﻀﺤﺎﹸ ﺨﻼل ﺍﻟﻔﺘﺭﺓ ﺍﻟﺤﺭﺠﺔ ﻓﻲ ﻓﺘﺭﺓ ﺍﻟﺘﻤﺎﻴﺯ
ﺃﺴﺎﺒﻴﻊ ﻤﺎ ﺒﻌﺩ ﺍﻟﻔﻘﺱ ﻭﺒﻌﺩ ﺇﻨﺘﻬﺎﺀ ﻫﺫﻩ ﺍﻟﻔﺘﺭﺓ ﻻ ﻴﻭﺠﺩ ﺃﻱ ﺘﺄﺜﻴﺭ ﻟﻬـﺫﻩ  6-ﺍﺴﺒﻭﻉ2ﺍﻟﻔﺘﺭﺓ ﺘﻜﻭﻥ ﻤﺎ ﺒﻴﻥ 
ﺨﻼل ﻫﺫﻩ ﺍﻟﻔﺘـﺭﺓ  2-XOCﺍﻷﺩﻭﻴﺔ ﻋﻠﻰ ﻤﻌﺩل ﺍﻟﻨﻤﻭ ﻭﻫﺫﺍ ﻴﻌﻨﻲ ﺃﻥ ﺍﺴﺘﺨﺩﺍﻡ ﺍﻷﺩﻭﻴﺔ ﺍﻟﻤﺜﺒﻁﺔ ﻹﻨﺯﻴﻡ 
ﻟﻀﺭﻭﺭﻱ ﻟﻠﺘﻁﻭﺭ ﺍﻟﺠﻨﺴﻲ ﺍﻟﻤﻨﺎﺴﺏ ﺍ esatamoraﺍﻟﺤﺭﺠﺔ ﻤﻥ ﺍﻟﻤﻤﻜﻥ ﺃﻥ ﻴﻐﻴﺭ ﻤﻥ ﻨﺸﺎﻁ ﺇﻨﺯﻴﻡ ﺍل 
ﺒﺎﻟﻨﺴﺒﺔ ﻟﻠﺘﻁﻭﺭ ﺍﻟﺠﻨﺴﻲ ﻓﻲ ﺍﻷﺴﻤﺎﻙ ، ﻭﻫـﺫﻩ ﺍﻟﻤـﺭﺓ ( ﺍﻟﺤﺴﺎﺴﺔ)ﻭﺍﻟﺘﻜﺎﺜﺭ ﺨﻼل ﻫﺫﻩ ﺍﻟﻔﺘﺭﺓ ﺍﻟﺤﺭﺠﺔ
ﺍﻷﻭﻟﻰ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻤﻌﺭﻓﺘﻨﺎ ﺍﻟﺘﻲ ﻴﺘﻡ ﻓﻴﻬﺎ ﺍﺨﺘﺒﺎﺭ ﺘﺄﺜﻴﺭ ﻫﺫﻩ ﺍﻟﻤﻭﺍﺩ ﻋﻠﻰ ﺼﻐﺎﺭ ﺍﻷﺴﻤﺎﻙ ﺨـﻼل ﺍﻟﻔﺘـﺭﺓ 
ﺘﻐﻴﻴﺭ ﺍﻟﺘﻜﺎﺜﺭ ﺒﻌﺩ ﺍﻟﺘﻌـﺭﺽ ﺍﻟﻁﻭﻴـل ﻟﻬـﺫﻩ ﺍﻟﺤﺴﺎﺴﺔ ﻤﻥ ﺍﻟﺘﻁﻭﺭ ﺍﻟﺠﻨﺴﻲ ﻭﺍﻟﺘﻲ ﺘﺸﻴﺭ ﺇﻟﻰ ﺍﺤﺘﻤﺎﻟﻴﺔ 
ﻭﺤﺘﻰ ﻨﺜﺒﺕ ﺫﻟﻙ ﻓﻌﻠﻴـﺎﹰ ﻨﺤـﻥ . ﺍﻷﺩﻭﻴﺔ ﻓﻲ ﺍﻟﻤﺭﺤﻠﺔ ﺍﻟﻤﺒﻜﺭﺓ ﻤﻥ ﺤﻴﺎﺘﻬﺎ ﻓﻲ ﺍﻟﻤﻴﺎﻩ ﺍﻟﺴﻁﺤﻴﺔ ﺍﻟﻤﻠﻭﺜﺔ 
ﺒﺤﺎﺠﺔ ﺇﻟﻰ ﺴﻠﺴﻠﺔ ﻤﺘﻭﺍﺼﻠﺔ ﻤﻥ ﺍﻟﺒﺤﺙ ﻓﻲ ﺍﻟﺒﺭﻙ ﺍﻟﺯﺭﺍﻋﻴﺔ ﻟﺘﺄﻜﻴﺩ ﻫﺫﻩ ﺍﻟﻨﺘﺎﺌﺞ ﻋﻠﻰ ﻤﺠﺘﻤﻌﺎﺕ ﺃﻜﺒـﺭ 
  .ﻭﺒﺘﺭﺍﻜﻴﺯ ﻤﺨﺘﻠﻔﺔ 2-XOCﻭﺃﻭﺴﻊ ﻭﺒﺎﺴﺘﺨﺩﺍﻡ ﺃﻨﻭﺍﻉ ﻤﺨﺘﻠﻔﺔ ﻤﻥ ﻤﺜﺒﻁﺎﺕ 
